{[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid
| Title | Journal |
|---|---|
| A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia. | Cancer treatment reviews 20121201 |
| Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China. | Medical oncology (Northwood, London, England) 20121201 |
| Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101 |
| Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype. | Leukemia & lymphoma 20121101 |
| Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities. | Journal of molecular medicine (Berlin, Germany) 20121101 |
| The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. | Investigational new drugs 20121001 |
| Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. | Bone marrow transplantation 20121001 |
| Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity. | Bone marrow transplantation 20121001 |
| Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group. | Leukemia & lymphoma 20121001 |
| Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India. | Leukemia & lymphoma 20121001 |
| N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity. | Leukemia 20121001 |
| Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. | Haematologica 20121001 |
| Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma. | Japanese journal of radiology 20121001 |
| Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia. | Leukemia research 20121001 |
| Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial. | British journal of haematology 20121001 |
| Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. | The Lancet. Oncology 20121001 |
| Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20120912 |
| Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity. | Journal of proteome research 20120907 |
| Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide. | Medical oncology (Northwood, London, England) 20120901 |
| Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning. | Bone marrow transplantation 20120901 |
| Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. | Bone marrow transplantation 20120901 |
| A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita. | Bone marrow transplantation 20120901 |
| Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. | Leukemia & lymphoma 20120901 |
| Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120901 |
| High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. | Haematologica 20120901 |
| Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. | Haematologica 20120901 |
| A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. | Annals of hematology 20120901 |
| Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma. | American journal of hematology 20120901 |
| Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. | Leukemia research 20120901 |
| Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. | Pediatric hematology and oncology 20120901 |
| Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up. | American journal of hematology 20120901 |
| Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20120901 |
| Hematopoietic stem cell transplantation for thalassemia. | Immunotherapy 20120901 |
| Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation. | Cancer 20120815 |
| ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. | Blood 20120809 |
| Treatment of older patients with mantle-cell lymphoma. | The New England journal of medicine 20120809 |
| Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity. | Bone marrow transplantation 20120801 |
| Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801 |
| Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801 |
| Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801 |
| Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor. | Annals of hematology 20120801 |
| Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients. | Leukemia 20120801 |
| Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia. | Clinical lymphoma, myeloma & leukemia 20120801 |
| Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120801 |
| In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase. | Cancer chemotherapy and pharmacology 20120801 |
| Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies. | Annals of the New York Academy of Sciences 20120801 |
| Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak. | Cell death & disease 20120801 |
| [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia]. | Zhongguo shi yan xue ye xue za zhi 20120801 |
| [Alleviation of palmoplantar pustulosis associated with adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120801 |
| Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. | Blood 20120712 |
| Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| [Modern times: back to past, back to future]. | Medicina clinica 20120707 |
| The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. | Leukemia & lymphoma 20120701 |
| Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. | Leukemia & lymphoma 20120701 |
| Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701 |
| Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. | Annals of hematology 20120701 |
| Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study. | Journal of cancer research and clinical oncology 20120701 |
| Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. | Biochemical pharmacology 20120701 |
| Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701 |
| miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. | Carcinogenesis 20120701 |
| Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. | Annals of the New York Academy of Sciences 20120701 |
| Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia. | Die Pharmazie 20120701 |
| T-cell large granular lymphocytic leukemia: treatment experience with fludarabine. | Clinics (Sao Paulo, Brazil) 20120701 |
| Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results. | Blood 20120628 |
| Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones. | Biochemical pharmacology 20120615 |
| Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia. | Gene 20120615 |
| Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. | Blood 20120607 |
| A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia. | Investigational new drugs 20120601 |
| Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. | Bone marrow transplantation 20120601 |
| Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601 |
| Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells. | Haematologica 20120601 |
| Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells. | Haematologica 20120601 |
| Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. | Experimental hematology 20120601 |
| Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia. | Journal of clinical immunology 20120601 |
| Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism. | Pediatric transplantation 20120601 |
| T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies. | British journal of haematology 20120601 |
| Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. | American journal of hematology 20120601 |
| Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia. | Pediatrics 20120601 |
| Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53. | Proteomics. Clinical applications 20120601 |
| A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma. | Current oncology (Toronto, Ont.) 20120601 |
| [Clinical analysis on 40 patients with chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20120601 |
| [Salvaged allogeneic hematopoietic stem cell transplantation for refractory/recurrent acute myeloid leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20120601 |
| Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. | Blood 20120531 |
| Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120510 |
| Risk categories and refractory CLL in the era of chemoimmunotherapy. | Blood 20120503 |
| Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT. | Bone marrow transplantation 20120501 |
| Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20120501 |
| Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide. | Annals of hematology 20120501 |
| Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant. | Leukemia & lymphoma 20120501 |
| The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature. | Leukemia & lymphoma 20120501 |
| Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells. | Leukemia & lymphoma 20120501 |
| Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines. | Leukemia & lymphoma 20120501 |
| Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia. | Leukemia 20120501 |
| Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20120501 |
| Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys. | Molecular therapy : the journal of the American Society of Gene Therapy 20120501 |
| The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT. | Bone marrow transplantation 20120501 |
| Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. | Blood reviews 20120501 |
| Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience. | British journal of haematology 20120501 |
| Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients. | Transplantation proceedings 20120501 |
| [Pretreatment doses of antithymocyte globubin-fresenius for allogeneic hematopoietic stem cell transplantation for beta-thalassemia major]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120501 |
| The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. | Oncotarget 20120501 |
| [Successful treatment with low-dose etoposide for hemophagocytic syndrome following reduced-intensity conditioning for cord blood transplantation in a patient with acute myelgenous leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120501 |
| Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. | Blood cancer journal 20120501 |
| Fludarabine may overcome resistance to rituximab in IgM-related neuropathy. | Journal of the neurological sciences 20120415 |
| Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. | Bone marrow transplantation 20120401 |
| Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. | Bone marrow transplantation 20120401 |
| Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation. | Bone marrow transplantation 20120401 |
| The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401 |
| SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. | Leukemia research 20120401 |
| AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. | Haematologica 20120401 |
| LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism. | Leukemia research 20120401 |
| Fludarabine and a histone deacetylase inhibitor - strange bedfellows. | Leukemia research 20120401 |
| Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients. | Journal of immunology (Baltimore, Md. : 1950) 20120401 |
| Rituximab for chronic lymphocytic leukemia. | Expert opinion on biological therapy 20120401 |
| FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients. | Journal of pediatric hematology/oncology 20120401 |
| Are reduced-intensity transplants safe in older patients with hematologic malignancies? | Expert review of hematology 20120401 |
| Waldenström macroglobulinemia. | Hematology (Amsterdam, Netherlands) 20120401 |
| Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009. | Croatian medical journal 20120401 |
| Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia. | Blood 20120329 |
| Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320 |
| Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120310 |
| Successful second bone marrow transplantation in Omenn's syndrome after bone marrow aplasia: a case report. | Pediatric transplantation 20120301 |
| Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. | Bone marrow transplantation 20120301 |
| FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame. | Hematological oncology 20120301 |
| Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo. | Bone marrow transplantation 20120301 |
| The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study. | Hematological oncology 20120301 |
| Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. | Bone marrow transplantation 20120301 |
| Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages. | Pediatric transplantation 20120301 |
| Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand? | Leukemia & lymphoma 20120301 |
| Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results. | Leukemia & lymphoma 20120301 |
| Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20120301 |
| Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. | Leukemia 20120301 |
| Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20120301 |
| Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301 |
| Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials. | Haematologica 20120301 |
| Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation. | Haematologica 20120301 |
| Fludarabine and rituximab for relapsed or refractory hairy cell leukemia. | Blood 20120301 |
| Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia. | American journal of hematology 20120301 |
| Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. | Human immunology 20120301 |
| Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. | Nature cell biology 20120301 |
| Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy. | The Korean journal of internal medicine 20120301 |
| A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy. | The Korean journal of internal medicine 20120301 |
| Bendamustine: inadequate or outdated data. | Prescrire international 20120301 |
| Epidemiology of astrovirus infection in children. | Korean journal of pediatrics 20120301 |
| Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation. | The Korean journal of hematology 20120301 |
| Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children. | The Korean journal of hematology 20120301 |
| [Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20120301 |
| Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. | Cancer research and treatment : official journal of Korean Cancer Association 20120301 |
| [Allogeneic peripheral blood stem cell transplantation from sibling donors for 10 patients with multiple myeloma]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20120301 |
| Alemtuzumab for patients with chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20120215 |
| Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR. | Bone marrow transplantation 20120201 |
| Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation. | Bone marrow transplantation 20120201 |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20120201 |
| Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility. | Annals of hematology 20120201 |
| T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. | Annals of oncology : official journal of the European Society for Medical Oncology 20120201 |
| Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201 |
| Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study. | Cancer chemotherapy and pharmacology 20120201 |
| Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosing. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201 |
| Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia. | Leukemia & lymphoma 20120201 |
| Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. | Leukemia & lymphoma 20120201 |
| Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44. | Journal of clinical immunology 20120201 |
| CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. | Haematologica 20120201 |
| Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders. | Clinical lymphoma, myeloma & leukemia 20120201 |
| Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201 |
| DNA building blocks: keeping control of manufacture. | Critical reviews in biochemistry and molecular biology 20120201 |
| Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20120201 |
| Individualized fludarabine-based regimen in elderly patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. | Advances in therapy 20120201 |
| MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. | Oncotarget 20120201 |
| Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. | The Journal of biological chemistry 20120120 |
| Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. | Cancer 20120115 |
| Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas. | Bone marrow transplantation 20120101 |
| Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study. | Bone marrow transplantation 20120101 |
| Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike. | Bone marrow transplantation 20120101 |
| Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis. | Annals of hematology 20120101 |
| Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin. | Leukemia & lymphoma 20120101 |
| Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials. | Leukemia & lymphoma 20120101 |
| Prostate-specific membrane antigen-based therapeutics. | Advances in urology 20120101 |
| Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia. | Leukemia & lymphoma 20120101 |
| Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia. | Advances in hematology 20120101 |
| A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients. | Cancer chemotherapy and pharmacology 20120101 |
| The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias. | Advances in hematology 20120101 |
| Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). | Molecular medicine (Cambridge, Mass.) 20120101 |
| FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment. | American journal of hematology 20120101 |
| Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. | British journal of haematology 20120101 |
| Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning. | European journal of haematology 20120101 |
| Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome. | American journal of hematology 20120101 |
| Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120101 |
| Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. | The Journal of allergy and clinical immunology 20120101 |
| Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine. | European journal of haematology 20120101 |
| Estimation of Abbreviated Cyclosporine A Area under the Concentration-Time Curve in Allogenic Stem Cell Transplantation after Oral Administration. | Journal of transplantation 20120101 |
| Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. | Cell death & disease 20120101 |
| Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. | Stem cells international 20120101 |
| Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. | Diagnostic pathology 20120101 |
| IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. | Journal of translational medicine 20120101 |
| Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. | Oncotarget 20120101 |
| The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. | PloS one 20120101 |
| Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells. | International journal of molecular sciences 20120101 |
| Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. | Journal of experimental & clinical cancer research : CR 20120101 |
| The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report. | Journal of medical case reports 20120101 |
| Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia. | Clinical Medicine Insights. Oncology 20120101 |
| Mannose-binding lectin 2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropaenia. | PloS one 20120101 |
| A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment. | PloS one 20120101 |
| TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets. | Clinical & developmental immunology 20120101 |
| Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. | Journal of hematology & oncology 20120101 |
| Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning? | Clinical transplantation 20120101 |
| Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution. | Infectious agents and cancer 20120101 |
| State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia. | Clinical Medicine Insights. Oncology 20120101 |
| 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma. | ISRN hematology 20120101 |
| Interferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders. | PloS one 20120101 |
| Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients. | Clinical & developmental immunology 20120101 |
| Modulation of Wnt5a expression by periodontopathic bacteria. | PloS one 20120101 |
| Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. | Molecular vision 20120101 |
| Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS. | International journal of general medicine 20120101 |
| Novel therapies for aggressive B-cell lymphoma. | Advances in hematology 20120101 |
| Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus? | Clinical Medicine Insights. Oncology 20120101 |
| Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways. | Cardiovascular diabetology 20120101 |
| The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes. | PloS one 20120101 |
| Immunotherapy for B-cell lymphoma: current status and prospective advances. | Frontiers in immunology 20120101 |
| Novel regulatory therapies for prevention of Graft-versus-host disease. | BMC medicine 20120101 |
| Therapy of elderly/comorbid patients with chronic lymphocytic leukemia. | Current pharmaceutical design 20120101 |
| Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. | International journal of molecular sciences 20120101 |
| Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis. | PloS one 20120101 |
| Immunotherapy targets in pediatric cancer. | Frontiers in oncology 20120101 |
| Acute myeloid leukemia: focus on novel therapeutic strategies. | Clinical Medicine Insights. Oncology 20120101 |
| Viral infection in renal transplant recipients. | TheScientificWorldJournal 20120101 |
| Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study. | Pharmacological reports : PR 20120101 |
| Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. | PloS one 20120101 |
| Chromosomal aberrations associated with clonal evolution and leukemic transformation in fanconi anemia: clinical and biological implications. | Anemia 20120101 |
| Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy. | Advances in urology 20120101 |
| Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation. | Stem cells international 20120101 |
| Hematopoietic stem cell function in a murine model of sickle cell disease. | Anemia 20120101 |
| Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine. | Journal of clinical and experimental hematopathology : JCEH 20120101 |
| Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma. | BMJ case reports 20120101 |
| Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101 |
| Successful treatment of γ-heavy-chain disease with rituximab and fludarabine. | Acta haematologica 20120101 |
| Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting. | Cancer cell international 20120101 |
| Heterogeneity of p53-pathway Protein Expression in Chemosensitive Chronic Lymphocytic Leukemia: A Pilot Study. | Journal of Cancer 20120101 |
| Bing and neel syndrome. | Case reports in hematology 20120101 |
| Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models. | Nucleosides, nucleotides & nucleic acids 20120101 |
| [Invasive mycoses during hematopoietic stem cell transplantation]. | Terapevticheskii arkhiv 20120101 |
| Chemotherapy: New FluCam combination therapy has familiar limitations. | Nature reviews. Clinical oncology 20111206 |
| FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia. | Medical oncology (Northwood, London, England) 20111201 |
| (90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma. | Bone marrow transplantation 20111201 |
| Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. | Bone marrow transplantation 20111201 |
| Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. | Bone marrow transplantation 20111201 |
| Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning. | Hematological oncology 20111201 |
| Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results. | Annals of hematology 20111201 |
| Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy. | Scandinavian journal of urology and nephrology 20111201 |
| Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111201 |
| Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. | Clinical lymphoma, myeloma & leukemia 20111201 |
| Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. | Leukemia & lymphoma 20111201 |
| Chronic lymphocytic leukemia in less fit patients: 'slow-go'. | Leukemia & lymphoma 20111201 |
| IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. | The Journal of investigative dermatology 20111201 |
| Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two? | Leukemia & lymphoma 20111201 |
| A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma. | Clinical lymphoma, myeloma & leukemia 20111201 |
| Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. | Leukemia & lymphoma 20111201 |
| The effects of chemotherapeutic agents on differentiated chordoma cells. | Journal of neurosurgery. Spine 20111201 |
| Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation. | International journal of clinical pharmacy 20111201 |
| Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. | The Lancet. Oncology 20111201 |
| Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. | The journal of gene medicine 20111201 |
| Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome. | The American Journal of dermatopathology 20111201 |
| Fludarabine nucleoside modulates nuclear 'survival and death' proteins in resistant chronic lymphocytic leukemia cells. | Nucleosides, nucleotides & nucleic acids 20111201 |
| Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. | PLoS computational biology 20111201 |
| Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'. | The Yale journal of biology and medicine 20111201 |
| Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient. | Experimental oncology 20111201 |
| [Recent advances of transplantation from bone marrow derived stem cells]. | Nihon rinsho. Japanese journal of clinical medicine 20111201 |
| Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases. | The Korean journal of hematology 20111201 |
| Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia. | Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20111201 |
| [HLA haploidentical peripheral blood stem cells transplantation for β thalassemia major]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20111201 |
| Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort. | Cancer 20111115 |
| Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study. | Blood 20111110 |
| Anti-CD20: tales of identical twins? | Blood 20111110 |
| Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. | JAMA 20111102 |
| Overcoming the age barrier in hematopoietic stem cell transplantation: progress, but still a long way to go. | JAMA 20111102 |
| Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. | International journal of radiation oncology, biology, physics 20111101 |
| Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes. | Bone marrow transplantation 20111101 |
| Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia. | Annals of hematology 20111101 |
| Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111101 |
| Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20111101 |
| Economic impact of disease progression in follicular non-Hodgkin lymphoma. | Leukemia & lymphoma 20111101 |
| Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia. | European journal of haematology 20111101 |
| The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality. | Haematologica 20111101 |
| Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. | Clinical immunology (Orlando, Fla.) 20111101 |
| Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial. | Molecular therapy : the journal of the American Society of Gene Therapy 20111101 |
| Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. | Journal of medical virology 20111101 |
| rILYd4, a human CD59 inhibitor, enhances complement-dependent cytotoxicity of ofatumumab against rituximab-resistant B-cell lymphoma cells and chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20111101 |
| Therapy-related myeloid neoplasms. | Current opinion in oncology 20111101 |
| Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study. | Cytometry. Part B, Clinical cytometry 20111101 |
| Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells. | Clinical and experimental immunology 20111101 |
| Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection. | International journal of hematology 20111101 |
| Isolation and characterization of a murine P388 leukemia line resistant to clofarabine. | Nucleosides, nucleotides & nucleic acids 20111101 |
| Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma. | Journal of pediatric surgery 20111101 |
| Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. | Oncotarget 20111101 |
| [Clinical study of kangai injection plus FLAG regimen for refractory/relapsed acute leukemia]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111101 |
| Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma. | Hematology reports 20111028 |
| Ongoing trials in low-grade lymphoma. | Hematology reports 20111028 |
| Case studies of elderly patients with non-Hodgkin's lymphoma. | Hematology reports 20111028 |
| Therapy related acute myeloid leukemia with t(10:16): a rare entity. | Hematology reports 20111019 |
| An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia. | Blood 20111013 |
| Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center. | Critical reviews in oncology/hematology 20111001 |
| Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4). | Bone marrow transplantation 20111001 |
| Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT. | Bone marrow transplantation 20111001 |
| Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001 |
| Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001 |
| Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab. | Annals of hematology 20111001 |
| Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial. | Haematologica 20111001 |
| Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications. | Annals of hematology 20111001 |
| Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia. | Leukemia & lymphoma 20111001 |
| Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis. | Leukemia & lymphoma 20111001 |
| Treatment strategies in patients with core-binding factor acute myeloid leukemia. | Current oncology reports 20111001 |
| Chronic lymphocytic leukemia: an update on biology and treatment. | Current oncology reports 20111001 |
| A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. | British journal of haematology 20111001 |
| Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia. | The Annals of pharmacotherapy 20111001 |
| Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia. | Current medical research and opinion 20111001 |
| Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria. | International journal of hematology 20111001 |
| Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia. | International journal of hematology 20111001 |
| Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma. | Journal of Korean medical science 20111001 |
| Acute abdomen after allogenic hematopoietic stem cell transplantation. | Pediatric reports 20110930 |
| Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. | Blood 20110929 |
| Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. | Blood 20110929 |
| Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. | Blood 20110922 |
| Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910 |
| A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients. | Cancer chemotherapy and pharmacology 20110901 |
| Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901 |
| Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. | Leukemia & lymphoma 20110901 |
| Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial. | Haematologica 20110901 |
| Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. | Blood 20110901 |
| Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. | British journal of haematology 20110901 |
| Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease. | Yonsei medical journal 20110901 |
| Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis. | International journal of hematology 20110901 |
| Tubulinosema sp. microsporidian myositis in immunosuppressed patient. | Emerging infectious diseases 20110901 |
| Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need. | Best practice & research. Clinical haematology 20110901 |
| Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial. | Expert review of anticancer therapy 20110901 |
| Umbilical cord blood: current status & promise for the future. | The Indian journal of medical research 20110901 |
| Comment on research report by Gruson and colleagues, this issue. | Journal of the peripheral nervous system : JPNS 20110901 |
| Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. | Journal of the peripheral nervous system : JPNS 20110901 |
| Low-grade lymphoma: Beyond fludarabine-single therapy. | The Korean journal of hematology 20110901 |
| Fortuitous detection of esophageal pneumatosis in a neutropenic patient. | The Korean journal of hematology 20110901 |
| Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma. | The Korean journal of hematology 20110901 |
| Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation. | Hematology reports 20110831 |
| Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. | Blood 20110825 |
| Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. | Blood 20110825 |
| Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia. | Blood 20110825 |
| [Scrotal ulcers revealing pulmonary and genitourinary tuberculosis]. | Dermatology online journal 20110815 |
| Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG. | Bone marrow transplantation 20110801 |
| Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801 |
| Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801 |
| NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801 |
| A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies. | Annals of oncology : official journal of the European Society for Medical Oncology 20110801 |
| Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD). | Pediatric blood & cancer 20110801 |
| Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia. | Haematologica 20110801 |
| Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110801 |
| Armed and targeted measles virus for chemovirotherapy of pancreatic cancer. | Cancer gene therapy 20110801 |
| Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. | Leukemia research 20110801 |
| Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801 |
| STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease. | Cytokine & growth factor reviews 20110801 |
| Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110801 |
| [The comparison of fludarabine or antithymocyte globulin based non-myeloablative conditioning regimen for haematologic diseases with graft-versus-host disease]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110801 |
| ⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma. | Blood 20110728 |
| Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110715 |
| Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. | Blood 20110714 |
| Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. | British journal of cancer 20110712 |
| High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Unrelated donor transplantation for acute myelogenous leukemia in first remission. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701 |
| Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma. | Annals of hematology 20110701 |
| Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy. | Leukemia research 20110701 |
| Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia. | European journal of haematology 20110701 |
| Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds. | Leukemia & lymphoma 20110701 |
| New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia. | American journal of hematology 20110701 |
| A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction. | British journal of haematology 20110701 |
| Pathology consultation on drug-induced hemolytic anemia. | American journal of clinical pathology 20110701 |
| Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses. | Leukemia & lymphoma 20110701 |
| Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia. | Leukemia & lymphoma 20110701 |
| Rituximab in chronic lymphocytic leukemia. | Advances in therapy 20110701 |
| Treatment of elderly patients with mantle cell lymphoma. | Seminars in hematology 20110701 |
| Proteins with complex architecture as potential targets for drug design: a case study of Mycobacterium tuberculosis. | PLoS computational biology 20110701 |
| Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation. | Pediatric reports 20110630 |
| Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. | Blood 20110623 |
| Reduced intensity transplantation for primary immunodeficiency disorders. | Pediatric reports 20110622 |
| HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors. | Pediatric reports 20110622 |
| T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients. | Pediatric reports 20110622 |
| T cell depleted haploidentical transplantation: positive selection. | Pediatric reports 20110622 |
| Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. | Pediatric reports 20110622 |
| Fanconi anemia - learning from children. | Pediatric reports 20110622 |
| Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. | Blood 20110616 |
| [Practical considerations and questions in the treatment of chronic lymphocytic leukemia]. | Orvosi hetilap 20110612 |
| Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC. | Blood 20110609 |
| MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature. | Pediatric transplantation 20110601 |
| A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. | Bone marrow transplantation 20110601 |
| Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. | Bone marrow transplantation 20110601 |
| Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601 |
| CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. | Leukemia research 20110601 |
| Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points. | Annals of oncology : official journal of the European Society for Medical Oncology 20110601 |
| STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. | American journal of physiology. Cell physiology 20110601 |
| Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience. | Journal of clinical immunology 20110601 |
| Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase. | Cancer gene therapy 20110601 |
| Purine analog toxicity in patients with hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601 |
| Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. | American journal of hematology 20110601 |
| Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia. | Leukemia & lymphoma 20110601 |
| Allogeneic stem cell transplantation in follicular lymphoma. | Best practice & research. Clinical haematology 20110601 |
| Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. | The Korean journal of internal medicine 20110601 |
| Chlorambucil--still not bad: a reappraisal. | Clinical lymphoma, myeloma & leukemia 20110601 |
| Fludarabine versus chlorambucil: is the debate over? | Clinical lymphoma, myeloma & leukemia 20110601 |
| Immunotoxins and other conjugates containing saporin-s6 for cancer therapy. | Toxins 20110601 |
| [Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities]. | Zhonghua yi xue za zhi 20110531 |
| Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. | Journal of immunology (Baltimore, Md. : 1950) 20110515 |
| Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse. | Cancer 20110515 |
| Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. | International journal of radiation oncology, biology, physics 20110501 |
| Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia. | International journal of cancer 20110501 |
| Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases. | Bone marrow transplantation 20110501 |
| EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. | Bone marrow transplantation 20110501 |
| Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. | Bone marrow transplantation 20110501 |
| Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT. | Bone marrow transplantation 20110501 |
| Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity. | Bone marrow transplantation 20110501 |
| Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| Diagnostic and therapeutic challenges. | Retina (Philadelphia, Pa.) 20110501 |
| The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501 |
| EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab. | Journal of neurology 20110501 |
| Chronic lymphocytic leukemia and autoimmunity: a systematic review. | Haematologica 20110501 |
| Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response. | Haematologica 20110501 |
| [Specific palatal infiltration in B-cell chronic lymphocytic leukemia]. | Actas dermo-sifiliograficas 20110501 |
| How I manage cold agglutinin disease. | British journal of haematology 20110501 |
| Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia. | Haematologica 20110501 |
| Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21). | Leukemia 20110501 |
| Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110501 |
| Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110501 |
| Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost? | Leukemia & lymphoma 20110501 |
| Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors. | American journal of hematology 20110501 |
| Mouse models of graft-versus-host disease: advances and limitations. | Disease models & mechanisms 20110501 |
| Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia. | Expert review of clinical immunology 20110501 |
| Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK. | Health technology assessment (Winchester, England) 20110501 |
| Alemtuzumab: what is the secret to safe therapy? | Clinical advances in hematology & oncology : H&O 20110501 |
| Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. | Blood 20110421 |
| Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. | Bone marrow transplantation 20110401 |
| Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. | Bone marrow transplantation 20110401 |
| T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression. | Annals of hematology 20110401 |
| Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110401 |
| Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. | Leukemia research 20110401 |
| Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients. | Leukemia research 20110401 |
| Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia. | Leukemia & lymphoma 20110401 |
| Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401 |
| Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age. | British journal of haematology 20110401 |
| Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. | British journal of haematology 20110401 |
| Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation. | International journal of hematology 20110401 |
| H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients. | Emerging infectious diseases 20110401 |
| BAG3: a multifaceted protein that regulates major cell pathways. | Cell death & disease 20110401 |
| The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins. | Indian journal of pharmacology 20110401 |
| Treatment of indolent lymphoma in Germany - results of a representative population-based survey. | Clinical lymphoma, myeloma & leukemia 20110401 |
| Inhibitory effect of leptin on rosiglitazone-induced differentiation of primary adipocytes prepared from TallyHO/Jng mice. | Biochemical and biophysical research communications 20110325 |
| Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. | Blood 20110317 |
| Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. | Journal of proteome research 20110304 |
| Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. | Journal of the National Cancer Institute 20110302 |
| Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301 |
| Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301 |
| Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL). | Annals of hematology 20110301 |
| APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells. | European journal of haematology 20110301 |
| Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning. | Leukemia 20110301 |
| Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. | Biochemical pharmacology 20110301 |
| A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. | British journal of haematology 20110301 |
| Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03). | Leukemia & lymphoma 20110301 |
| Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia. | Journal of pediatric hematology/oncology 20110301 |
| Early initial therapy of advanced follicular lymphoma: the need for vigilance. | Leukemia & lymphoma 20110301 |
| Optimal pharmacotherapeutic management of chronic lymphocytic leukaemia: considerations in the elderly. | Drugs & aging 20110301 |
| Recent advances in anti-angiogenic therapy of cancer. | Oncotarget 20110301 |
| NK cell-based immunotherapy for treating cancer: will it be promising? | The Korean journal of hematology 20110301 |
| [Successful combination therapy by meropenem and colistin for multi-drug-resistant Pseudomonas aeruginosa infection after allogeneic bone marrow transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20110301 |
| Depressogenic effects of medications: a review. | Dialogues in clinical neuroscience 20110301 |
| The treatment of pediatric chronic myelogenous leukemia in the imatinib era. | Korean journal of pediatrics 20110301 |
| Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy. | Pediatric reports 20110224 |
| Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors. | Journal of the National Cancer Institute 20110216 |
| ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. | Oncogene 20110210 |
| Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial. | Bone marrow transplantation 20110201 |
| Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. | Annals of hematology 20110201 |
| Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. | Haematologica 20110201 |
| Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells. | Transplant international : official journal of the European Society for Organ Transplantation 20110201 |
| Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110201 |
| Spotlight on rituximab in chronic lymphocytic leukemia, low-grade or follicular lymphoma, and diffuse large B-cell lymphoma. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110201 |
| The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells. | Oligonucleotides 20110201 |
| Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications. | International journal of hematology 20110201 |
| Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning. | Leukemia & lymphoma 20110201 |
| Personalizing treatment for chronic lymphocytic leukemia. | Expert review of hematology 20110201 |
| Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. | Expert review of anticancer therapy 20110201 |
| [A preliminary study on efficacy of allogeneic hematopoietic stem cell transplantation by myeloablative conditioning regimen with fludarabine for high risk leukemia patients]. | Zhongguo shi yan xue ye xue za zhi 20110201 |
| [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110201 |
| Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120 |
| The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling. | Biochemical pharmacology 20110115 |
| Systemic absorption of topical lidocaine in a bone marrow transplant recipient with hepatic sinusoidal obstruction syndrome. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110115 |
| Synthesis and biological properties of the cytotoxic 14-membered macrolides aspergillide A and B. | Chemistry (Weinheim an der Bergstrasse, Germany) 20110110 |
| Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. | Blood 20110106 |
| Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia. | Blood 20110106 |
| Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. | Bone marrow transplantation 20110101 |
| High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation. | Bone marrow transplantation 20110101 |
| Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. | Bone marrow transplantation 20110101 |
| Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. | Bone marrow transplantation 20110101 |
| Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101 |
| Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome. | Annals of hematology 20110101 |
| A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. | Cytotherapy 20110101 |
| Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia. | Cancer immunology, immunotherapy : CII 20110101 |
| Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia. | Leukemia & lymphoma 20110101 |
| Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia. | Journal of medical microbiology 20110101 |
| The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients. | Advances in hematology 20110101 |
| Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer. | Journal of biomedicine & biotechnology 20110101 |
| Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. | Journal of oncology 20110101 |
| Cord blood transplantation in children with relapsed or refractory severe aplastic anemia. | Journal of pediatric hematology/oncology 20110101 |
| U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia. | The oncologist 20110101 |
| Systematic review of medical treatment in melanoma: current status and future prospects. | The oncologist 20110101 |
| A transient IgE monoclonal protein in a child. | Annals of clinical biochemistry 20110101 |
| FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases. | Journal of experimental & clinical cancer research : CR 20110101 |
| Immunotherapy for lung cancers. | Journal of biomedicine & biotechnology 20110101 |
| The role of HDACs inhibitors in childhood and adolescence acute leukemias. | Journal of biomedicine & biotechnology 20110101 |
| Immune-based therapies for sarcoma. | Sarcoma 20110101 |
| Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH. | PloS one 20110101 |
| Role of rituximab in first-line treatment of chronic lymphocytic leukemia. | Therapeutics and clinical risk management 20110101 |
| Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial. | BMC cancer 20110101 |
| Aggressive cutaneous vasculitis in a patient with chronic lymphatic leukemia following granulocyte colony stimulating factor injection: a case report. | Journal of medical case reports 20110101 |
| Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome. | Journal of hematology & oncology 20110101 |
| Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia. | Diagnostic pathology 20110101 |
| Reduced-intensity conditioning regimen combined with low-dose total body irradiation in the treatment of myelodysplastic syndrome. | Acta haematologica 20110101 |
| [Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101 |
| Therapeutics formulated to target cancer stem cells: Is it in our future? | Cancer cell international 20110101 |
| An illustrative case of subcutaneous panniculitis-like T-cell lymphoma. | Journal of skin cancer 20110101 |
| A patient with splenic marginal zone lymphoma presenting with spastic paraplegia as the initial symptom. | Case reports in neurology 20110101 |
| Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation. | Journal of experimental & clinical cancer research : CR 20110101 |
| Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis. | BMC medicine 20110101 |
| Apoptotic sphingolipid ceramide in cancer therapy. | Journal of lipids 20110101 |
| Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines. | Journal of experimental & clinical cancer research : CR 20110101 |
| The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia. | Clinical Medicine Insights. Oncology 20110101 |
| Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. | Journal of hematology & oncology 20110101 |
| Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies. | Journal of biomedicine & biotechnology 20110101 |
| Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant. | Case reports in medicine 20110101 |
| A Case of Drug-Induced Hepatitis due to Lenalidomide. | Case reports in gastroenterology 20110101 |
| Congenital neutropenia: diagnosis, molecular bases and patient management. | Orphanet journal of rare diseases 20110101 |
| SULFs in human neoplasia: implication as progression and prognosis factors. | Journal of translational medicine 20110101 |
| Risk factors and options to improve engraftment in unrelated cord blood transplantation. | Stem cells international 20110101 |
| MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines. | BMC cancer 20110101 |
| What are fungal infections? | Mediterranean journal of hematology and infectious diseases 20110101 |
| Myelodysplastic syndrome and histone deacetylase inhibitors: 'to be or not to be acetylated'? | Journal of biomedicine & biotechnology 20110101 |
| [Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia]. | Gaceta sanitaria 20110101 |
| Circulating microRNAs: potential biomarkers for cancer. | International journal of molecular sciences 20110101 |
| Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. | BMC blood disorders 20110101 |
| The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. | Advances in hematology 20110101 |
| Clearing the complexity: immune complexes and their treatment in lupus nephritis. | International journal of nephrology and renovascular disease 20110101 |
| Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma. | Clinical Medicine Insights. Oncology 20110101 |
| Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies. | PloS one 20110101 |
| Immune Reactions following Cord Blood Transplantations in Adults. | Stem cells international 20110101 |
| Adoptive cell therapy for patients with melanoma. | Journal of Cancer 20110101 |
| T cell therapy for nasopharyngeal carcinoma. | Journal of Cancer 20110101 |
| Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). | Journal of Cancer 20110101 |
| Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab. | BMC nephrology 20110101 |
| Evolving role of high dose stem cell therapy in multiple myeloma. | Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101 |
| Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy. | Journal of translational medicine 20110101 |
| Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. | Neoplasma 20110101 |
| Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. | Journal of biomedicine & biotechnology 20110101 |
| Peripheral T-Cell lymphoma manifested as gingival enlargement in a patient with chronic lymphocytic leukemia. | Journal of Indian Society of Periodontology 20110101 |
| Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia. | Cancer management and research 20110101 |
| Haploidentical allogeneic haematopoietic stem cell transplantation as salvage therapy for engraftment failure after unrelated and autologous stem cell transplantation: a case report and review of the literature. | The Journal of international medical research 20110101 |
| Mesenchymal stem cells: angels or demons? | Journal of biomedicine & biotechnology 20110101 |
| Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. | PloS one 20110101 |
| The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. | Molecular cancer 20110101 |
| Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-Hodgkin lymphoma: a case report. | Journal of medical case reports 20110101 |
| Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. | PloS one 20110101 |
| Mechanisms of resistance to decitabine in the myelodysplastic syndrome. | PloS one 20110101 |
| Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer. | Journal of translational medicine 20110101 |
| Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer. | BMC cancer 20110101 |
| Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia. | Mediterranean journal of hematology and infectious diseases 20110101 |
| Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen. | Medical science monitor : international medical journal of experimental and clinical research 20110101 |
| Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells. | PloS one 20110101 |
| Fermented wheat germ extract--nutritional supplement or anticancer drug? | Nutrition journal 20110101 |
| Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma. | Clinical laboratory science : journal of the American Society for Medical Technology 20110101 |
| Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagy. | PloS one 20110101 |
| Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia. | OncoTargets and therapy 20110101 |
| Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case report. | Journal of medical case reports 20110101 |
| Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience. | International journal of immunopathology and pharmacology 20110101 |
| Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients. | Hematology/oncology and stem cell therapy 20110101 |
| Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component. | PloS one 20110101 |
| Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation. | Onkologie 20110101 |
| Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines. | BMC cancer 20110101 |
| Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review. | Diagnostic pathology 20110101 |
| Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression. | PloS one 20110101 |
| Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells. | PloS one 20110101 |
| Recent advance in antigen-specific immunotherapy for acute myeloid leukemia. | Clinical & developmental immunology 20110101 |
| Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells. | BMC cancer 20110101 |
| Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy. | Bone marrow research 20110101 |
| Haploidentical hematopoietic stem-cell transplantation in adults. | Bone marrow research 20110101 |
| Transplantation for congenital bone marrow failure syndromes. | Bone marrow research 20110101 |
| Antibody-based therapies in multiple myeloma. | Bone marrow research 20110101 |
| Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors. | BMC cancer 20110101 |
| A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. | Journal of hematology & oncology 20110101 |
| Coexisting pulmonary tuberculosis and mucormycosis in a patient with aplastic anemia post allogenic stem cell transplantation. | Mediterranean journal of hematology and infectious diseases 20110101 |
| A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. | ISRN hematology 20110101 |
| IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. | PloS one 20110101 |
| Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency. | Case reports in medicine 20110101 |
| Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies. | BMC infectious diseases 20110101 |
| Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis. | Journal of signal transduction 20110101 |
| Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review. | World journal of nuclear medicine 20110101 |
| Using the biology of chronic lymphocytic leukemia to choose treatment. | Hematology. American Society of Hematology. Education Program 20110101 |
| The treatment of relapsed refractory chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20110101 |
| Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia. [corrected]. | Hematology. American Society of Hematology. Education Program 20110101 |
| Targeted treatment for chronic lymphocytic leukemia. | OncoTargets and therapy 20110101 |
| Aleukemic leukemia cutis manifesting with disseminated nodular eruptions and a plaque preceding acute monocytic leukemia: a case report. | Case reports in oncology 20110101 |
| Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease. | Advances in hematology 20110101 |
| The immune response to tumors as a tool toward immunotherapy. | Clinical & developmental immunology 20110101 |
| Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect. | Hematology/oncology and stem cell therapy 20110101 |
| Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors. | Mediterranean journal of hematology and infectious diseases 20110101 |
| Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. | Clinical epigenetics 20110101 |
| Synovial tissue response to treatment in psoriatic arthritis. | The open rheumatology journal 20110101 |
| Role of ofatumumab in treatment of chronic lymphocytic leukemia. | Journal of blood medicine 20110101 |
| Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation. | American journal of blood research 20110101 |
| Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation. | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101 |
| Cell death signaling and anticancer therapy. | Frontiers in oncology 20110101 |
| Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia. | Frontiers in oncology 20110101 |
| Ribonucleotide reductase inhibitors: a new look at an old target for radiosensitization. | Frontiers in oncology 20110101 |
| Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. | Blood 20101223 |
| Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. | Lancet (London, England) 20101211 |
| Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. | British journal of cancer 20101207 |
| CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies. | Bone marrow transplantation 20101201 |
| Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages. | Shock (Augusta, Ga.) 20101201 |
| Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. | Annals of oncology : official journal of the European Society for Medical Oncology 20101201 |
| Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. | Gene therapy 20101201 |
| Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. | Bone marrow transplantation 20101201 |
| Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. | Experimental hematology 20101201 |
| PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients. | Archives of virology 20101201 |
| Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies. | Experimental hematology 20101201 |
| Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus. | Human pathology 20101201 |
| Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. | Leukemia & lymphoma 20101201 |
| Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination. | Leukemia & lymphoma 20101201 |
| Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia. | Leukemia & lymphoma 20101201 |
| Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. | Leukemia 20101201 |
| Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation. | International journal of hematology 20101201 |
| Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring. | Leukemia & lymphoma 20101201 |
| Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome. | Hematological oncology 20101201 |
| The DAC system and associations with acute leukemias and myelodysplastic syndromes. | Investigational new drugs 20101201 |
| The European Medicines Agency review of ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use. | The oncologist 20101201 |
| Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia. | The Netherlands journal of medicine 20101201 |
| DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells. | Experimental oncology 20101201 |
| Novel agents for the treatment of chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20101201 |
| [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation]. | Methods and findings in experimental and clinical pharmacology 20101201 |
| The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment. | Blood 20101125 |
| Effect of FCGR2A and FCGR3A variants on CLL outcome. | Blood 20101118 |
| The clinical application of monoclonal antibodies in chronic lymphocytic leukemia. | Blood 20101111 |
| The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study. | Bone marrow transplantation 20101101 |
| Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. | Annals of hematology 20101101 |
| Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors. | Annals of hematology 20101101 |
| Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. | Transfusion 20101101 |
| Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101 |
| Cross-talk between STAT1 and PI3K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis. | Journal of neuroscience research 20101101 |
| Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance. | Haematologica 20101101 |
| Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. | The Journal of allergy and clinical immunology 20101101 |
| Allogeneic natural killer cells for refractory lymphoma. | Cancer immunology, immunotherapy : CII 20101101 |
| Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101 |
| The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia. | Current oncology reports 20101101 |
| B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells. | Leukemia 20101101 |
| A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL. | Leukemia 20101101 |
| Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients. | Leukemia & lymphoma 20101101 |
| Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk? | Leukemia & lymphoma 20101101 |
| Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells. | Oncology reports 20101101 |
| Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution. | American journal of hematology 20101101 |
| Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation. | Transplantation proceedings 20101101 |
| Human health risk assessment of pharmaceuticals in water: issues and challenges ahead. | International journal of environmental research and public health 20101101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20101101 |
| Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells? | Clinics (Sao Paulo, Brazil) 20101101 |
| Refractory chronic lymphocytic leukemia--new therapeutic strategies. | Oncotarget 20101101 |
| High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. | Blood 20101028 |
| Heating up cold agglutinins. | Blood 20101028 |
| Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. | Blood 20101021 |
| Beyond hairy cell: the activity of cladribine in other hematologic malignancies. | Blood 20101021 |
| Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia. | Blood 20101007 |
| Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. | Blood 20101007 |
| Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. | Lancet (London, England) 20101002 |
| HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD. | Bone marrow transplantation 20101001 |
| Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101001 |
| Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method. | Annals of hematology 20101001 |
| Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study. | Cancer immunology, immunotherapy : CII 20101001 |
| Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. | Diabetes 20101001 |
| HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus. | Journal of hepatology 20101001 |
| Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience. | Pediatric hematology and oncology 20101001 |
| Successful treatment of melanoma brain metastases with adoptive cell therapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20101001 |
| The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. | British journal of haematology 20101001 |
| Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. | Leukemia & lymphoma 20101001 |
| Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia. | Leukemia 20101001 |
| Current immunochemotherapy strategies in follicular lymphoma. | Advances in therapy 20101001 |
| What's new in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. | Expert review of anticancer therapy 20101001 |
| Chronic lymphocytic leukemia. | Annals of oncology : official journal of the European Society for Medical Oncology 20101001 |
| Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemia. | Clinical lymphoma, myeloma & leukemia 20101001 |
| Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia. | Health technology assessment (Winchester, England) 20101001 |
| The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. | Health technology assessment (Winchester, England) 20101001 |
| Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20101001 |
| Ofatumumab: chronic lymphocytic leukaemia: a last resort. | Prescrire international 20101001 |
| Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS). | Cancer 20100915 |
| Modifying akt signaling in B-cell chronic lymphocytic leukemia cells. | Cancer research 20100915 |
| Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study. | Blood 20100909 |
| Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. | Bone marrow transplantation 20100901 |
| Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. | Bone marrow transplantation 20100901 |
| MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings. | Bone marrow transplantation 20100901 |
| Rapid vision loss associated with fludarabine administration. | Retina (Philadelphia, Pa.) 20100901 |
| Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine. | The international journal of biochemistry & cell biology 20100901 |
| Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease. | Acta neuropathologica 20100901 |
| Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. | Cancer gene therapy 20100901 |
| U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100901 |
| Chemoimmunotherapy of chronic lymphocytic leukemia. | Nature reviews. Clinical oncology 20100901 |
| LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. | Leukemia 20100901 |
| Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results. | American journal of hematology 20100901 |
| Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901 |
| Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities. | International journal of hematology 20100901 |
| Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors. | The Korean journal of internal medicine 20100901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100901 |
| Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children. | The Korean journal of hematology 20100901 |
| Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. | British journal of cancer 20100824 |
| The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results. | Journal of medicine and life 20100815 |
| Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia. | Blood 20100812 |
| T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100810 |
| Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. | Cancer chemotherapy and pharmacology 20100801 |
| Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL. | American journal of hematology 20100801 |
| Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. | Bone marrow transplantation 20100801 |
| High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia. | European journal of cancer (Oxford, England : 1990) 20100801 |
| Auer rod-like inclusions in a low-grade B-cell leukemia. | Annals of diagnostic pathology 20100801 |
| [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol]. | Orvosi hetilap 20100801 |
| Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL). | Clinical lymphoma, myeloma & leukemia 20100801 |
| Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eye. | Clinical lymphoma, myeloma & leukemia 20100801 |
| [Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation]. | Zhongguo shi yan xue ye xue za zhi 20100801 |
| [Bone marrow failure due to telomere associated gene mutation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100801 |
| Diffusion-weighted magnetic resonance imaging in acute reversible toxic leukoencephalopathy: A report of two cases. | The Indian journal of radiology & imaging 20100801 |
| Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events. | Clinical advances in hematology & oncology : H&O 20100801 |
| Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma. | Drugs 20100730 |
| Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. | Blood 20100729 |
| Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. | European journal of pharmacology 20100725 |
| Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720 |
| Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710 |
| Inhibition of STAT1 accelerates bone fracture healing. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100701 |
| Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials. | Haematologica 20100701 |
| Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. | Leukemia research 20100701 |
| Prognostic factor and quality of life analysis in 160 patients aged > or =60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100701 |
| Donor-derived second hematologic malignancies after cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100701 |
| Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. | Cancer investigation 20100701 |
| Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL. | European journal of haematology 20100701 |
| Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic. | Cytotherapy 20100701 |
| Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia. | The American journal of the medical sciences 20100701 |
| Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. | Leukemia 20100701 |
| Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas. | British journal of haematology 20100701 |
| Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. | International journal of oncology 20100701 |
| Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options. | Leukemia & lymphoma 20100701 |
| Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma. | International journal of hematology 20100701 |
| The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100701 |
| Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies. | Environmental and molecular mutagenesis 20100701 |
| Ofatumumab in the treatment of chronic lymphocytic leukemia. | Drugs of today (Barcelona, Spain : 1998) 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. | Blood 20100624 |
| Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100614 |
| Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100610 |
| Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. | Blood 20100603 |
| T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience. | Medical oncology (Northwood, London, England) 20100601 |
| Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells. | Molecular and cellular biochemistry 20100601 |
| Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601 |
| Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601 |
| Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601 |
| Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. | British journal of haematology 20100601 |
| Regulatory T cell as a target for cancer therapy. | Archivum immunologiae et therapiae experimentalis 20100601 |
| Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. | Haematologica 20100601 |
| Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy. | Muscle & nerve 20100601 |
| Role of CD20 monoclonal antibodies in previously untreated chronic lymphocytic leukemia. | Clinical lymphoma, myeloma & leukemia 20100601 |
| The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. | Hematology (Amsterdam, Netherlands) 20100601 |
| [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells]. | Zhongguo shi yan xue ye xue za zhi 20100601 |
| Paramyxovirus entry and targeted vectors for cancer therapy. | PLoS pathogens 20100601 |
| Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission. | The Korean journal of hematology 20100601 |
| Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide. | The Korean journal of hematology 20100601 |
| Ofatumumab. | Drugs 20100528 |
| Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510 |
| The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. | Toxicology letters 20100504 |
| Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience. | Bone marrow transplantation 20100501 |
| Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. | Bone marrow transplantation 20100501 |
| Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. | Journal of cellular physiology 20100501 |
| Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder. | Journal of Korean medical science 20100501 |
| Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab. | The Netherlands journal of medicine 20100501 |
| Medical applications and toxicities of gallium compounds. | International journal of environmental research and public health 20100501 |
| First siRNA library screening in hard-to-transfect HUVEC cells. | Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research 20100501 |
| A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. | Cell death & disease 20100501 |
| All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism. | The Journal of biological chemistry 20100430 |
| Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410 |
| A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma. | Biomedical chromatography : BMC 20100401 |
| [Brucella bacteremia reactivation 70 years after the primary infection]. | Medecine et maladies infectieuses 20100401 |
| Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients. | Leukemia research 20100401 |
| Keratotic vascular papules over the feet: a case of Waldenström's macroglobulinaemia-associated cutaneous macroglobulinosis. | Clinical and experimental dermatology 20100401 |
| The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100401 |
| Haematopoeitic cell transplantation for Fanconi anaemia - when and how? | British journal of haematology 20100401 |
| Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients. | American journal of hematology 20100401 |
| Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma. | American journal of hematology 20100401 |
| Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis. | American journal of hematology 20100401 |
| Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients. | Journal of pediatric hematology/oncology 20100401 |
| Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. | Leukemia & lymphoma 20100401 |
| Rituximab-associated infections. | Seminars in hematology 20100401 |
| Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia. | Journal of Korean medical science 20100401 |
| Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. | The Journal of allergy and clinical immunology 20100401 |
| Chronic lymphocytic leukemia: putting new treatment options into perspective. | Cancer control : journal of the Moffitt Cancer Center 20100401 |
| Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis. | Current hematologic malignancy reports 20100401 |
| [Female case of successful engraftment after PBSCT from her HLA-haploidentical son for severe aplastic anemia during maintenance peritoneal dialysis]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100401 |
| [Fungal infections in oncohematology: the role of prophylaxis]. | Drugs of today (Barcelona, Spain : 1998) 20100401 |
| Rituximab. Chronic lymphoid leukaemia: no decisive advantage. | Prescrire international 20100401 |
| Incidence and susceptibility to therapy-related myeloid neoplasms. | Chemico-biological interactions 20100319 |
| HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer. | Bone marrow transplantation 20100301 |
| Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years. | Leukemia research 20100301 |
| Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience. | Bone marrow transplantation 20100301 |
| Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. | Bone marrow transplantation 20100301 |
| Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma. | Annals of hematology 20100301 |
| Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301 |
| The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. | European journal of haematology 20100301 |
| Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma. | British journal of haematology 20100301 |
| R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia. | Leukemia 20100301 |
| The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. | British journal of haematology 20100301 |
| 188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation. | British journal of haematology 20100301 |
| CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia. | Experimental hematology 20100301 |
| Changing paradigms in the treatment of chronic lymphocytic leukemia. | Leukemia 20100301 |
| Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine. | Leukemia 20100301 |
| Ofatumumab, a human anti-CD20 monoclonal antibody. | Expert opinion on biological therapy 20100301 |
| Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301 |
| Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient. | International journal of hematology 20100301 |
| A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas. | Leukemia & lymphoma 20100301 |
| Clinical and imaging features of fludarabine neurotoxicity. | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20100301 |
| Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab. | The Korean journal of internal medicine 20100301 |
| Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. | Pediatric hematology and oncology 20100301 |
| [Early relapse of hemophagocytic syndrome after reduced-intensity cord blood transplantation for relapsed acute lymphoblastic leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301 |
| Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. | Collegium antropologicum 20100301 |
| Therapy of chronic lymphocytic leukaemia. | Best practice & research. Clinical haematology 20100301 |
| Monoclonal antibody therapy of chronic lymphocytic leukaemia. | Best practice & research. Clinical haematology 20100301 |
| Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. | Best practice & research. Clinical haematology 20100301 |
| NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. | Blood 20100211 |
| A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. | Blood 20100204 |
| Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma. | Pediatric transplantation 20100201 |
| Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. | Bone marrow transplantation 20100201 |
| Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine. | Bone marrow transplantation 20100201 |
| The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20100201 |
| Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment. | Transfusion 20100201 |
| Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR). | British journal of haematology 20100201 |
| [Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20100201 |
| Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. | Clinical lymphoma, myeloma & leukemia 20100201 |
| Bone marrow transplantation for inherited bone marrow failure syndromes. | Pediatric clinics of North America 20100201 |
| Drug-induced immune hemolytic anemia. | Clinical advances in hematology & oncology : H&O 20100201 |
| Clofarabine in leukemia. | Expert review of hematology 20100201 |
| Dural MALT lymphoma with disseminated disease. | Hematology reports 20100126 |
| Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. | Blood 20100121 |
| Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100120 |
| Continuous non-invasive monitoring of the skin temperature of HSCT recipients. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101 |
| Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. | Bone marrow transplantation 20100101 |
| Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT. | Bone marrow transplantation 20100101 |
| Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100101 |
| Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100101 |
| Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia. | Hemodialysis international. International Symposium on Home Hemodialysis 20100101 |
| Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia. | Leukemia 20100101 |
| Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate. | Biopharmaceutics & drug disposition 20100101 |
| IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100101 |
| R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. | Journal of cellular biochemistry 20100101 |
| Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation. | British journal of haematology 20100101 |
| Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activation in vitro. | Leukemia & lymphoma 20100101 |
| New agents for the treatment of genetically high-risk chronic lymphocytic leukemia. | Leukemia & lymphoma 20100101 |
| Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Novel therapeutic approaches in systemic lupus erythematosus. | Frontiers in bioscience (Scholar edition) 20100101 |
| A case of pathologic splenic rupture as the initial manifestation of acute myeloid leukemia M2. | Yonsei medical journal 20100101 |
| T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report. | Cases journal 20100101 |
| Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. | Scandinavian journal of rheumatology 20100101 |
| Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature. | Dermatology (Basel, Switzerland) 20100101 |
| Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index. | International journal of nanomedicine 20100101 |
| An unusual cause of visual loss after Herpes zoster ophthalmicus: a case report. | Cases journal 20100101 |
| Acquired haemophilia a in the elderly: case reports. | Current gerontology and geriatrics research 20100101 |
| Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report. | Virology journal 20100101 |
| Successful treatment of cutaneous intravascular large B-cell lymphoma with fludarabine phosphate. | European journal of dermatology : EJD 20100101 |
| Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression. | Acta haematologica 20100101 |
| Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy. | Journal of biomedicine & biotechnology 20100101 |
| Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab. | Chemotherapy 20100101 |
| A rare occurrence of hairy cell leukemia in the Thai population: a case report. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100101 |
| [Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia]. | Terapevticheskii arkhiv 20100101 |
| Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. | Journal of hematology & oncology 20100101 |
| MKEM: a Multi-level Knowledge Emergence Model for mining undiscovered public knowledge. | BMC bioinformatics 20100101 |
| Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights. | Journal of hematology & oncology 20100101 |
| Fludarabine-induced bradycardia in a patient with refractory leukemia. | Annals of Saudi medicine 20100101 |
| Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study. | Health and quality of life outcomes 20100101 |
| Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia. | BMC cancer 20100101 |
| MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies. | Journal of oncology 20100101 |
| Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. | BMC infectious diseases 20100101 |
| Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. | PloS one 20100101 |
| The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo. | PloS one 20100101 |
| Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies. | Human antibodies 20100101 |
| Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients. | Cell transplantation 20100101 |
| First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab. | OncoTargets and therapy 20100101 |
| Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience. | Journal of biomedicine & biotechnology 20100101 |
| Challenges in treating older patients with acute myeloid leukemia. | Journal of oncology 20100101 |
| Use of clofarabine for acute childhood leukemia. | Biologics : targets & therapy 20100101 |
| Eosinophilic panniculitis and insect bite-like eruption in a patient with chronic lymphocytic leukaemia: a spectrum of the same entity. | Dermatology research and practice 20100101 |
| Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma. | Journal of hematology & oncology 20100101 |
| Immune hemolytic anemia associated with drug therapy. | Blood reviews 20100101 |
| Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients. | Advances in hematology 20100101 |
| The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. | Journal of molecular signaling 20100101 |
| Recent advances in the treatment of acute myeloid leukemia. | F1000 medicine reports 20100101 |
| Molecular and therapeutic potential and toxicity of valproic acid. | Journal of biomedicine & biotechnology 20100101 |
| Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. | BMC neurology 20100101 |
| Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma. | Journal of hematology & oncology 20100101 |
| Prozone effect of serum IgE levels in a case of plasma cell leukemia. | Journal of hematology & oncology 20100101 |
| Vitamin D in combination cancer treatment. | Journal of Cancer 20100101 |
| [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia]. | Terapevticheskii arkhiv 20100101 |
| Biclonal follicular lymphoma: histological, clinical and molecular characteristics. | Pathology 20100101 |
| Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma. | OncoTargets and therapy 20100101 |
| Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia. | Advances in hematology 20100101 |
| Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia. | Journal of hematology & oncology 20100101 |
| Aminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation. | GMS Krankenhaushygiene interdisziplinar 20100101 |
| Decompressive abdominal laparotomy for abdominal compartment syndrome in an unengrafted bone marrow recipient with septic shock. | Critical care research and practice 20100101 |
| Overview of cellular immunotherapy for patients with glioblastoma. | Clinical & developmental immunology 20100101 |
| Human vocal cord infection with the Microsporidium Anncaliia algerae. | The Journal of eukaryotic microbiology 20100101 |
| The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology. | CytoJournal 20100101 |
| The effects of forodesine in murine and human multiple myeloma cells. | Advances in hematology 20100101 |
| Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. | Acta haematologica 20100101 |
| Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP). | PloS one 20100101 |
| Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males. | BMC medical genomics 20100101 |
| Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. | PloS one 20100101 |
| Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs). | PloS one 20100101 |
| Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? | Infectious agents and cancer 20100101 |
| Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia. | Journal of hematology & oncology 20100101 |
| [Influence of hepatitis C virus replication on splenic lymphoma with villous lymphocytes]. | Acta medica portuguesa 20100101 |
| Nelarabine in the treatment of refractory T-cell malignancies. | Clinical Medicine Insights. Oncology 20100101 |
| Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Rituximab for the treatment of patients with chronic lymphocytic leukemia. | Cancer management and research 20100101 |
| Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma. | Cancer management and research 20100101 |
| Treatment of cutaneous melanoma: current approaches and future prospects. | Cancer management and research 20100101 |
| Rituximab administration and reactivation of HBV. | Hepatitis research and treatment 20100101 |
| Can engineered 'designer' T cells outsmart chronic hepatitis B? | Hepatitis research and treatment 20100101 |
| Focus on adoptive T cell transfer trials in melanoma. | Clinical & developmental immunology 20100101 |
| Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas. | Advances in hematology 20100101 |
| The spectrum of use of rituximab in chronic lymphocytic leukemia. | OncoTargets and therapy 20100101 |
| How I treat elderly or comorbid patients with chronic lymphocytic leukemia. | Acta medica (Hradec Kralove) 20100101 |
| Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Application of new drugs in chronic lymphocytic leukemia. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Role of allogeneic transplantation in multiple myeloma in the era of new drugs. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when? | Mediterranean journal of hematology and infectious diseases 20100101 |
| Role and timing of hematopoietic cell transplantation for myelodysplastic syndrome. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Allogeneic transplantation for chronic lymphocytic leukemia. | Mediterranean journal of hematology and infectious diseases 20100101 |
| Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. | Clinical & developmental immunology 20100101 |
| Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness. | ClinicoEconomics and outcomes research : CEOR 20100101 |
| Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. | International journal of proteomics 20100101 |
| The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies. | Journal of blood medicine 20100101 |
| Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL). | Journal of blood medicine 20100101 |
| Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. | Blood 20091224 |
| Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. | Blood 20091217 |
| Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. | Blood 20091217 |
| IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. | Annals of hematology 20091201 |
| Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia. | Bone marrow transplantation 20091201 |
| Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia. | Irish journal of medical science 20091201 |
| Mechanisms of anti-cancer action and pharmacology of clofarabine. | Biochemical pharmacology 20091201 |
| Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis. | Leukemia 20091201 |
| Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response. | British journal of haematology 20091201 |
| Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab. | Journal of hepatology 20091201 |
| Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression. | Leukemia & lymphoma 20091201 |
| Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201 |
| Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation. | The Korean journal of internal medicine 20091201 |
| Optimising the conditioning regimen for acute myeloid leukaemia. | Best practice & research. Clinical haematology 20091201 |
| [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation]. | Zhongguo shi yan xue ye xue za zhi 20091201 |
| [FLAG regimen as consolidation therapy for patients with acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20091201 |
| The role of regulatory T cells in cancer. | Immune network 20091201 |
| [The clinical features and risk factors for invasive fungal infection in multiple myeloma.]. | Zhonghua nei ke za zhi 20091201 |
| [A multicenter retrospective analysis of diagnosis and treatment of 72 hemophagocytic syndrome patients.]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20091201 |
| In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia. | Internal medicine journal 20091201 |
| Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. | Cancer 20091115 |
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. | Blood 20091105 |
| Antineoplastic activity of idazoxan hydrochloride. | Cancer chemotherapy and pharmacology 20091101 |
| Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. | Bone marrow transplantation 20091101 |
| The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. | Leukemia 20091101 |
| Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study. | Leukemia 20091101 |
| Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients. | Experimental hematology 20091101 |
| 5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101 |
| Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia. | British journal of haematology 20091101 |
| Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro. | British journal of haematology 20091101 |
| Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF. | American journal of hematology 20091101 |
| Bendamustine-associated hemolytic anemia. | The Annals of pharmacotherapy 20091101 |
| Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101 |
| The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. | Cancer research 20091101 |
| Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101 |
| Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. | Journal of hematopathology 20091101 |
| Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling. | British journal of cancer 20091020 |
| Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. | British journal of cancer 20091020 |
| First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. | Blood 20091015 |
| Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children. | Leukemia research 20091001 |
| Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma. | Cancer chemotherapy and pharmacology 20091001 |
| Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. | Leukemia research 20091001 |
| Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. | Leukemia 20091001 |
| Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. | Leukemia 20091001 |
| Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation. | Transplant infectious disease : an official journal of the Transplantation Society 20091001 |
| Diagnosis by sheer coincidence. | The international journal of cardiovascular imaging 20091001 |
| Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma. | Cancer science 20091001 |
| Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma. | British journal of haematology 20091001 |
| Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer. | Pancreas 20091001 |
| Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia. | International journal of hematology 20091001 |
| Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival. | Leukemia & lymphoma 20091001 |
| FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. | American journal of hematology 20091001 |
| Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091001 |
| Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way. | Leukemia & lymphoma 20091001 |
| The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial. | Leukemia & lymphoma 20091001 |
| Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution. | Journal of Korean medical science 20091001 |
| [Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia]. | Zhongguo shi yan xue ye xue za zhi 20091001 |
| [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome]. | Zhongguo shi yan xue ye xue za zhi 20091001 |
| Modern concepts in the treatment of chronic lymphocytic leukemia. | Hematology (Amsterdam, Netherlands) 20091001 |
| Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. | Clinical lymphoma & myeloma 20091001 |
| Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. | Leukemia & lymphoma 20091001 |
| p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy. | Leukemia & lymphoma 20091001 |
| Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature. | Tennessee medicine : journal of the Tennessee Medical Association 20091001 |
| Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia. | Current hematologic malignancy reports 20091001 |
| Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. | Blood 20090924 |
| Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920 |
| Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. | Lancet (London, England) 20090912 |
| Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies. | Pediatric transplantation 20090901 |
| Chronic lymphocytic leukemia: treatment options for patients with refractory disease. | Cancer 20090901 |
| Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic? | British journal of haematology 20090901 |
| Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review. | International journal of hematology 20090901 |
| High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901 |
| Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901 |
| Rituximab for polyneuropathy with IgM monoclonal gammopathy. | Journal of neurology, neurosurgery, and psychiatry 20090901 |
| Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia. | Haematologica 20090901 |
| Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. | Haematologica 20090901 |
| Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL. | Annals of the New York Academy of Sciences 20090901 |
| Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma. | Health technology assessment (Winchester, England) 20090901 |
| I-Tositumomab in lymphoma. | Current oncology (Toronto, Ont.) 20090901 |
| Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors. | Journal of hematopathology 20090901 |
| Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. | Blood 20090820 |
| Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. | Blood 20090820 |
| Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820 |
| IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. | Journal of immunology (Baltimore, Md. : 1950) 20090815 |
| A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090815 |
| Calcineurin-inhibitor-induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia. | Pediatric transplantation 20090801 |
| Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. | Leukemia research 20090801 |
| Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting. | Bone marrow transplantation 20090801 |
| Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing. | British journal of haematology 20090801 |
| Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. | Leukemia & lymphoma 20090801 |
| Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801 |
| A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801 |
| Immunotherapy of distant metastatic disease. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation. | Journal of Korean medical science 20090801 |
| Successful salvage unrelated umbilical cord blood transplantation with two units after engraftment failure with single unit in severe aplastic anemia. | Journal of Korean medical science 20090801 |
| [High-dose methylprednisolone for the treatment of refractory chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20090801 |
| Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. | Annals of the New York Academy of Sciences 20090801 |
| [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801 |
| [Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801 |
| [Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801 |
| [Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801 |
| Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090715 |
| Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures. | Leukemia research 20090701 |
| Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia. | Leukemia research 20090701 |
| In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis. | European journal of haematology 20090701 |
| Novel therapies for peripheral T-cell non-Hodgkin's lymphomas. | Current opinion in hematology 20090701 |
| Treatment of fludarabine-refractory chronic lymphocytic leukemia. | Cancer 20090701 |
| Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090701 |
| Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. | Cancer research 20090701 |
| Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation. | Journal of pediatric hematology/oncology 20090701 |
| [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20090701 |
| T-regulatory cell modulation: the future of cancer immunotherapy? | British journal of cancer 20090602 |
| Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT. | Leukemia research 20090601 |
| The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions. | Bone marrow transplantation 20090601 |
| Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome. | Bone marrow transplantation 20090601 |
| Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. | American journal of physiology. Renal physiology 20090601 |
| A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. | British journal of haematology 20090601 |
| Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090601 |
| Clofarabine: a new treatment option for patients with acute myeloid leukemia. | Expert opinion on pharmacotherapy 20090601 |
| Genzyme takes Campath bet. | Nature biotechnology 20090601 |
| Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity. | Mini reviews in medicinal chemistry 20090601 |
| Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation. | The Korean journal of internal medicine 20090601 |
| The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia. | Journal of Korean medical science 20090601 |
| [Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20090601 |
| Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia. | Current opinion in oncology 20090601 |
| Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. | Health technology assessment (Winchester, England) 20090601 |
| Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen. | International journal of clinical oncology 20090601 |
| Pentostatin treatment combinations in chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20090601 |
| [Toxoplasmosis after immunosuppressive therapy--our experience]. | Klinicka mikrobiologie a infekcni lekarstvi 20090601 |
| Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090601 |
| Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. | Blood 20090528 |
| Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. | Blood 20090507 |
| Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. | Bone marrow transplantation 20090501 |
| Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. | Bone marrow transplantation 20090501 |
| Oxidative stress and delta-ALA-D activity in different conditioning regimens in allogeneic bone marrow transplantation patients. | Clinical biochemistry 20090501 |
| Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation. | Pediatric blood & cancer 20090501 |
| A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma. | Leukemia 20090501 |
| Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. | Cancer 20090501 |
| Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. | European journal of pharmacology 20090501 |
| [Anti-CD20 in hematologic oncology]. | Presse medicale (Paris, France : 1983) 20090501 |
| Current treatments of chronic immune-mediated demyelinating polyneuropathies. | Muscle & nerve 20090501 |
| Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090501 |
| Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs. | International journal of oncology 20090501 |
| Busulfan in hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090501 |
| Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090501 |
| Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia. | Journal of clinical pathology 20090501 |
| Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. | Ophthalmology 20090501 |
| Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. | Archives of neurology 20090501 |
| Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. | International journal of radiation biology 20090501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090501 |
| Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia. | Blood 20090416 |
| Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation. | Cancer genetics and cytogenetics 20090415 |
| Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. | Blood 20090402 |
| Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens. | Blood 20090402 |
| Intracellular disposition of fludarabine triphosphate in human natural killer cells. | Cancer chemotherapy and pharmacology 20090401 |
| Central and peripheral nervous system toxicity of common chemotherapeutic agents. | Cancer chemotherapy and pharmacology 20090401 |
| Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. | American journal of hematology 20090401 |
| Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20090401 |
| [IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia]. | Zhongguo shi yan xue ye xue za zhi 20090401 |
| A kernel for open source drug discovery in tropical diseases. | PLoS neglected tropical diseases 20090401 |
| A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia. | Internal medicine journal 20090401 |
| A single apheresis procedure in the donor may be enough to complete an allograft using the 'Mexican method' of non-ablative allografting. | Blood transfusion = Trasfusione del sangue 20090401 |
| Alemtuzumab: new indication. First line treatment of chronic lymphocytic leukaemia: continue to use oral chlorambucil. | Prescrire international 20090401 |
| Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation. | Blood 20090326 |
| Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. | Molecules (Basel, Switzerland) 20090323 |
| Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. | Blood 20090319 |
| Follicular lymphoma in the United States: first report of the national LymphoCare study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy. | Pediatric transplantation 20090301 |
| Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma. | Annals of hematology 20090301 |
| Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. | Leukemia 20090301 |
| Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. | Bone marrow transplantation 20090301 |
| Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. | Bone marrow transplantation 20090301 |
| HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. | Microvascular research 20090301 |
| Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men? | Nature clinical practice. Oncology 20090301 |
| Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study. | American journal of hematology 20090301 |
| Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function. | American journal of hematology 20090301 |
| Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab. | Leukemia & lymphoma 20090301 |
| Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. | Leukemia & lymphoma 20090301 |
| Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia. | Leukemia & lymphoma 20090301 |
| Assessment of bone marrow response in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Rituximab-based treatments in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Fludarabine-based combination therapies for Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Development of cell-cycle inhibitors for cancer therapy. | Current oncology (Toronto, Ont.) 20090301 |
| Allogeneic hematopoietic cell transplantation for patients with myelofibrosis. | Current opinion in hematology 20090301 |
| A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients. | Cancer chemotherapy and pharmacology 20090201 |
| Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia. | Leukemia research 20090201 |
| Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. | Annals of hematology 20090201 |
| Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro. | Journal of cancer research and clinical oncology 20090201 |
| Successful allogeneic unrelated bone marrow transplantation using reduced-intensity conditioning for the treatment of X-linked adrenoleukodystrophy in a one-yr-old boy. | Pediatric transplantation 20090201 |
| Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors. | Bone marrow transplantation 20090201 |
| Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator. | Leukemia 20090201 |
| Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. | European journal of haematology 20090201 |
| Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. | British journal of haematology 20090201 |
| Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20090201 |
| Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090201 |
| Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study. | Leukemia & lymphoma 20090201 |
| Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. | Onkologie 20090201 |
| Registry of Hospital das Clínicas of the University of São Paulo Medical School: first official solid organ and tissue transplantation report - 2008. | Clinics (Sao Paulo, Brazil) 20090201 |
| Alkylating agents for Waldenstrom's macroglobulinaemia. | The Cochrane database of systematic reviews 20090121 |
| Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120 |
| Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. | Blood 20090115 |
| Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110 |
| Dasatinib induces a response in chronic lymphocytic leukemia. | Blood 20090108 |
| Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures. | Cancer chemotherapy and pharmacology 20090101 |
| A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia. | Annals of hematology 20090101 |
| Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. | Bone marrow transplantation 20090101 |
| AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. | Blood 20090101 |
| Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. | Immunologic research 20090101 |
| Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. | Haematologica 20090101 |
| [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment]. | Presse medicale (Paris, France : 1983) 20090101 |
| Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20090101 |
| Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG). | British journal of haematology 20090101 |
| Central nervous system infections in immunocompromised patients: update on diagnostics and therapy. | Leukemia & lymphoma 20090101 |
| Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. | Haematologica 20090101 |
| Radiosensitization by inhibiting STAT1 in renal cell carcinoma. | International journal of radiation oncology, biology, physics 20090101 |
| Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101 |
| Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role. | Journal of ovarian research 20090101 |
| Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen. | Cytotherapy 20090101 |
| Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report. | Cases journal 20090101 |
| Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. | BMC molecular biology 20090101 |
| [Treatment of Waldenström macroglobulinaemia--the experience of one centre]. | Vnitrni lekarstvi 20090101 |
| ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC. | BMC cancer 20090101 |
| Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. | PloS one 20090101 |
| Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins. | Journal of biomedical science 20090101 |
| Chronic lymphocytic leukaemia: current first-line therapy. | Internal medicine journal 20090101 |
| R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature. | Journal of hematology & oncology 20090101 |
| Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections. | Clinical transplantation 20090101 |
| Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages. | PloS one 20090101 |
| Delta-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients. | BMC cancer 20090101 |
| Fludarabine in the treatment of chronic lymphocytic leukemia: a review. | Therapeutics and clinical risk management 20090101 |
| FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. | Immunologic research 20090101 |
| Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101 |
| Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin. | Clinical interventions in aging 20090101 |
| STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. | PloS one 20090101 |
| Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? | Breast cancer research : BCR 20090101 |
| A 15-year-old girl with pancytopenia and congenital defects. | Annals of Saudi medicine 20090101 |
| Update in the management of chronic lymphocytic leukemia. | Journal of hematology & oncology 20090101 |
| 9-Aminoacridine inhibition of HIV-1 Tat dependent transcription. | Virology journal 20090101 |
| Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone. | Tumori 20090101 |
| Economic burden of follicular non-Hodgkin's lymphoma. | PharmacoEconomics 20090101 |
| Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. | Journal of translational medicine 20090101 |
| Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis. | Acta dermato-venereologica 20090101 |
| [Cost-reduction analysis for oral versus intravenous fludarabine (Beneflur) in Spain]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report. | Cases journal 20090101 |
| Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report. | Journal of medical case reports 20090101 |
| Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy. | PloS one 20090101 |
| Re-transplantation from the same unrelated donor in three adolescents with severe aplastic anemia after graft rejection. | Klinische Padiatrie 20090101 |
| STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect. | BMC medicine 20090101 |
| Current and emerging treatments for chronic lymphocytic leukaemia. | Drugs 20090101 |
| Full response of a localized renal tumour after reduced-intensity conditioned hematopoietic stem cell transplantation. | Case reports in medicine 20090101 |
| An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals. | Molecular cancer 20090101 |
| Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT. | Journal of experimental & clinical cancer research : CR 20090101 |
| Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia. | Advances in hematology 20090101 |
| Drug-induced hematologic syndromes. | Advances in hematology 20090101 |
| Drug-induced immune hemolytic anemia. | Hematology. American Society of Hematology. Education Program 20090101 |
| Immune hemolytic anemia--selected topics. | Hematology. American Society of Hematology. Education Program 20090101 |
| State-of-the-art treatment of chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20090101 |
| Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway. | PloS one 20090101 |
| New targets for the treatment of follicular lymphoma. | Journal of hematology & oncology 20090101 |
| Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review. | Advances in hematology 20090101 |
| Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer. | Journal of oncology 20090101 |
| Treatment options for ocular adnexal lymphoma (OAL). | Clinical ophthalmology (Auckland, N.Z.) 20090101 |
| Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia. | Drug design, development and therapy 20090101 |
| An immunocompetent patient presenting with severe nasal herpes simplex: a case report. | Cases journal 20090101 |
| Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. | Biomarker insights 20090101 |
| Non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy: a case report. | Cases journal 20090101 |
| Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series. | Cases journal 20090101 |
| Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. | Oxidative medicine and cellular longevity 20090101 |
| Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia. | International journal of general medicine 20090101 |
| Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy. | Indian journal of human genetics 20090101 |
| Role of bendamustine in the treatment of chronic lymphocytic leukemia. | OncoTargets and therapy 20090101 |
| Expanded use of rituximab in the management of non-Hodgkin lymphoma. | OncoTargets and therapy 20090101 |
| Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma. | OncoTargets and therapy 20090101 |
| Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia. | OncoTargets and therapy 20090101 |
| Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin's lymphoma. | OncoTargets and therapy 20090101 |
| Bendamustine in the treatment of non-Hodgkin's lymphomas. | OncoTargets and therapy 20090101 |
| Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. | F1000 medicine reports 20090101 |
| The role of azacitidine in the management of myelodysplastic syndromes (MDS). | Cancer management and research 20090101 |
| Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma. | Cancer management and research 20090101 |
| The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma. | Cancer management and research 20090101 |
| Management of HBV infection during immunosuppressive treatment. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Aplastica anemia and viral hepatitis. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Hematopietic stem cell transplantation in thalassemia and related disorders. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population. | Mediterranean journal of hematology and infectious diseases 20090101 |
| Epstein-barr virus related lymphoproliferations after stem cell transplantation. | Mediterranean journal of hematology and infectious diseases 20090101 |
| c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. | Blood 20081215 |
| The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081215 |
| Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. | British journal of cancer 20081209 |
| A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. | Pediatric transplantation 20081201 |
| Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years. | Leukemia research 20081201 |
| Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia. | Hematological oncology 20081201 |
| Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia. | Oral and maxillofacial surgery 20081201 |
| Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose. | Bone marrow transplantation 20081201 |
| 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20081201 |
| Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival. | Cancer 20081201 |
| Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells. | Haematologica 20081201 |
| Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. | British journal of haematology 20081201 |
| Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. | British journal of haematology 20081201 |
| Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. | Molecular cancer research : MCR 20081201 |
| Small-molecule Bcl-2 antagonists as targeted therapy in oncology. | Current oncology (Toronto, Ont.) 20081201 |
| Rituximab in the treatment of non-Hodgkin's lymphoma. | Biologics : targets & therapy 20081201 |
| Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. | Journal of medicinal chemistry 20081113 |
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110 |
| Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells. | Mutation research 20081110 |
| Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. | Molecular and cellular endocrinology 20081106 |
| Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration. | Annals of hematology 20081101 |
| Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. | Leukemia 20081101 |
| Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. | Blood 20081101 |
| Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20081101 |
| Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases. | European journal of haematology 20081101 |
| p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. | Blood 20081101 |
| Images in haematology. Cerebral nocardiosis in a patient with lymphoplasmacytic lymphoma treated with fludarabine. | British journal of haematology 20081101 |
| Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. | Leukemia 20081101 |
| Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. | Journal of clinical pathology 20081101 |
| Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience. | British journal of haematology 20081101 |
| Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy. | Haematologica 20081101 |
| Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma. | International journal of hematology 20081101 |
| Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101 |
| Mycobacterium haemophilum infection after alemtuzumab treatment. | Emerging infectious diseases 20081101 |
| Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. | British journal of haematology 20081101 |
| [Limited but potential efficacy by graft-versus-leukemia (GVL) for Pro T-ALL]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. | European journal of medical research 20081027 |
| Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020 |
| Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. | Blood 20081015 |
| Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. | Transplantation 20081015 |
| Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. | Investigational new drugs 20081001 |
| Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. | Cancer chemotherapy and pharmacology 20081001 |
| Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues. | Leukemia research 20081001 |
| Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction. | Diabetes 20081001 |
| Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. | Leukemia & lymphoma 20081001 |
| Novel human antibody therapeutics: the age of the Umabs. | Biotechnology journal 20081001 |
| High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia. | British journal of haematology 20081001 |
| Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. | International journal of hematology 20081001 |
| Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081001 |
| [Chronic lymphocytic leukemia and the related disorders]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20081001 |
| Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. | Molecular cancer therapeutics 20081001 |
| HSCT for Fanconi anemia in children: factors that influence early and late results. | Bone marrow transplantation 20081001 |
| Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia. | Bone marrow transplantation 20081001 |
| Treating recurrent cases of squamous cell carcinoma with radiotherapy. | Current oncology (Toronto, Ont.) 20081001 |
| Survival from non-Hodgkin lymphoma in England and Wales up to 2001. | British journal of cancer 20080923 |
| Survival from adult leukaemia in England and Wales up to 2001. | British journal of cancer 20080923 |
| Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. | Chinese medical journal 20080920 |
| Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. | Cancer 20080915 |
| Imatinib inhibition of fludarabine uptake in T-lymphocytes. | Cancer chemotherapy and pharmacology 20080901 |
| Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records. | Leukemia 20080901 |
| Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis. | Clinical rheumatology 20080901 |
| The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia. | British journal of haematology 20080901 |
| Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. | Blood 20080901 |
| Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients. | American journal of hematology 20080901 |
| Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease. | Haematologica 20080901 |
| Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. | QJM : monthly journal of the Association of Physicians 20080901 |
| Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia. | Current oncology reports 20080901 |
| Pentostatin in chronic lymphocytic leukemia. | Expert opinion on drug metabolism & toxicology 20080901 |
| Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901 |
| Unrelated cord blood transplantation for severe aplastic anemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901 |
| Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. | Molecular cancer therapeutics 20080901 |
| Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience. | Pediatric transplantation 20080901 |
| Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside. | Biologics : targets & therapy 20080901 |
| Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias. | Biologics : targets & therapy 20080901 |
| Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia. | Biologics : targets & therapy 20080901 |
| Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. | Blood 20080815 |
| The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. | Blood 20080815 |
| Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation. | International journal of radiation oncology, biology, physics 20080801 |
| Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. | Pharmacy world & science : PWS 20080801 |
| Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor. | American journal of hematology 20080801 |
| Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. | Bone marrow transplantation 20080801 |
| Acquired pure red cell aplasia: updated review of treatment. | British journal of haematology 20080801 |
| Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801 |
| The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro. | International journal of radiation biology 20080801 |
| [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab]. | Zhongguo shi yan xue ye xue za zhi 20080801 |
| Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma. | Bone marrow transplantation 20080801 |
| Bone marrow and stem cell transplantation at King Hussein cancer center. | Bone marrow transplantation 20080801 |
| Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. | Leukemia & lymphoma 20080801 |
| [Allogeneic hematopoietic stem cell transplantation following reduced intensity conditioning regimen for treatment of refractory leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080801 |
| Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin's lymphoma. | Therapeutics and clinical risk management 20080801 |
| Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. | Blood 20080715 |
| lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080715 |
| CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. | British journal of cancer 20080708 |
| Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. | Leukemia research 20080701 |
| Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. | Transplant infectious disease : an official journal of the Transplantation Society 20080701 |
| Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure. | Bone marrow transplantation 20080701 |
| Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen. | Bone marrow transplantation 20080701 |
| Selective killing of Mycobacterium avium-infected macrophages by inhibition of phosphorylated signal transducer and activator of transcription type 1. | The Journal of infectious diseases 20080701 |
| Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. | European journal of cancer (Oxford, England : 1990) 20080701 |
| Alemtuzumab for B-cell chronic lymphocytic leukemia. | Expert review of anticancer therapy 20080701 |
| Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403. | Haematologica 20080701 |
| Frontline therapy for chronic lymphocytic leukemia: the dilemma continues. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080701 |
| [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080701 |
| Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab. | Blood 20080615 |
| DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080615 |
| [Novel medical treatment modalities in hematology]. | Ugeskrift for laeger 20080609 |
| Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both? | Bone marrow transplantation 20080601 |
| Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party. | Hematological oncology 20080601 |
| CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair. | Bone marrow transplantation 20080601 |
| Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies. | Cellular signalling 20080601 |
| Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma. | Leukemia 20080601 |
| Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia. | Leukemia & lymphoma 20080601 |
| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601 |
| Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia. | British journal of haematology 20080601 |
| Targeted therapies in Waldenström macroglobulinemia. | Current opinion in investigational drugs (London, England : 2000) 20080601 |
| Non-MALT marginal zone lymphomas. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Ofatumumab, a human monoclonal antibody for lymphoid malignancies and autoimmune disorders. | Current opinion in molecular therapeutics 20080601 |
| Fludarabine induces differential expression of proteins in human leukemia and lymphoma cells. | Nucleosides, nucleotides & nucleic acids 20080601 |
| Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. | Journal of cellular biochemistry 20080515 |
| Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity. | Biochemical pharmacology 20080515 |
| Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma. | Cancer immunology, immunotherapy : CII 20080501 |
| CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia. | Pediatric blood & cancer 20080501 |
| Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study. | Annals of hematology 20080501 |
| IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. | Blood 20080501 |
| A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation. | Bone marrow transplantation 20080501 |
| The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. | Blood 20080501 |
| Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants. | Bone marrow transplantation 20080501 |
| Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13. | Journal of molecular medicine (Berlin, Germany) 20080501 |
| Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. | Cancer 20080501 |
| Mutated and non-mutated TP53 as targets in the treatment of leukaemia. | British journal of haematology 20080501 |
| Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. | Experimental hematology 20080501 |
| Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20080501 |
| Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080501 |
| Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience. | International journal of hematology 20080501 |
| Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. | Cancer investigation 20080501 |
| Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols. | Saudi medical journal 20080501 |
| Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20080501 |
| The apoptosome: emerging insights and new potential targets for drug design. | Pharmaceutical research 20080401 |
| Liposomal coencapsulated fludarabine and mitoxantrone for lymphoproliferative disorder treatment. | Journal of pharmaceutical sciences 20080401 |
| Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. | Bone marrow transplantation 20080401 |
| Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia. | European journal of haematology 20080401 |
| High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. | Bone marrow transplantation 20080401 |
| Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20080401 |
| Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ). | The Lancet. Oncology 20080401 |
| Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401 |
| Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401 |
| Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401 |
| Antibody therapy for chronic lymphocytic leukemia. | Seminars in hematology 20080401 |
| Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. | Leukemia & lymphoma 20080401 |
| Use of TAGVHD warnings in patients receiving purine analogue chemotherapy. | Transfusion medicine (Oxford, England) 20080401 |
| Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future. | Onkologie 20080401 |
| Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase. | Onkologie 20080401 |
| Alemtuzumab in the up-front setting. | Therapeutics and clinical risk management 20080401 |
| Treating refractory leukemias in childhood, role of clofarabine. | Therapeutics and clinical risk management 20080401 |
| Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. | Cancer 20080315 |
| Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080315 |
| Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. | Pediatric blood & cancer 20080301 |
| Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine. | Leukemia 20080301 |
| Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation. | Bone marrow transplantation 20080301 |
| Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. | Leukemia 20080301 |
| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. | Haematologica 20080301 |
| Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080301 |
| Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia. | Leukemia & lymphoma 20080301 |
| Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16. | British journal of haematology 20080301 |
| Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. | British journal of haematology 20080301 |
| Phase I trial of nelarabine in indolent leukemias. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301 |
| Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma. | Haematologica 20080301 |
| High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. | Haematologica 20080301 |
| Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia. | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20080301 |
| [Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic stem cell transplantation]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301 |
| Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation. | JPMA. The Journal of the Pakistan Medical Association 20080301 |
| Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL). | Biologics : targets & therapy 20080301 |
| Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). | Biologics : targets & therapy 20080301 |
| Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei. | The Journal of biological chemistry 20080227 |
| Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma. | Yonsei medical journal 20080227 |
| STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. | Blood 20080215 |
| Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. | Blood 20080215 |
| The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. | Blood 20080215 |
| Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. | Biochemical pharmacology 20080215 |
| A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma. | Cancer 20080215 |
| Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient. | Leukemia research 20080201 |
| Extramedullary, extranodal lymphoplasmacytic lymphoma with macroglobulinemia: long-term complete remission with fludarabine. | Annals of hematology 20080201 |
| Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. | International journal of radiation oncology, biology, physics 20080201 |
| Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. | Bone marrow transplantation 20080201 |
| Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. | Leukemia 20080201 |
| Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. | Cell death and differentiation 20080201 |
| Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. | Bone marrow transplantation 20080201 |
| Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. | Blood 20080201 |
| Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis. | Blood 20080201 |
| Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. | Bone marrow transplantation 20080201 |
| Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma. | Bone marrow transplantation 20080201 |
| Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. | Blood 20080201 |
| Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. | British journal of haematology 20080201 |
| Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group. | European journal of haematology 20080201 |
| Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. | Pediatric transplantation 20080201 |
| Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201 |
| Invasive fungal sinusitis in patients treated with fludarabine. | The Journal of infection 20080201 |
| Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201 |
| Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience. | Haematologica 20080201 |
| Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. | Haematologica 20080201 |
| High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. | Haematologica 20080201 |
| Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma. | Leukemia & lymphoma 20080201 |
| Allogeneic peripheral blood stem cell transplantation from related donors mismatched at 2 HLA loci in the host-versus-graft direction. | The Tohoku journal of experimental medicine 20080201 |
| Unrelated bone marrow transplantation with a reduced toxicity myeloablative conditioning regimen in Wiskott-Aldrich syndrome. | Journal of Korean medical science 20080201 |
| Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080201 |
| Pharmacovigilance: Safety matters…. | Indian journal of pharmacology 20080201 |
| BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. | Blood 20080115 |
| Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells. | Transplantation 20080115 |
| Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110 |
| Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110 |
| A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders. | Leukemia research 20080101 |
| Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. | Blood cells, molecules & diseases 20080101 |
| Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab. | Leukemia research 20080101 |
| Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. | Blood cells, molecules & diseases 20080101 |
| Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. | Experimental hematology 20080101 |
| Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. | Bone marrow transplantation 20080101 |
| Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. | Cancer 20080101 |
| Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through activation of the Jak2 tyrosine kinase pathway in vascular endothelial cells. | The international journal of biochemistry & cell biology 20080101 |
| The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. | Haematologica 20080101 |
| Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080101 |
| Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20080101 |
| Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma. | Leukemia & lymphoma 20080101 |
| Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance. | Journal of translational medicine 20080101 |
| Waldenström macroglobulinemia of the orbit. | Ophthalmic plastic and reconstructive surgery 20080101 |
| Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation. | International journal of hematology 20080101 |
| Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico. | Pediatric hematology and oncology 20080101 |
| Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy. | Clinical transplantation 20080101 |
| The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias. | BMC medical research methodology 20080101 |
| [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]. | Vnitrni lekarstvi 20080101 |
| Prodrug converting enzyme gene delivery by L. monocytogenes. | BMC cancer 20080101 |
| Paradoxical exacerbation of psoriasis during therapy with fludarabine. | European journal of dermatology : EJD 20080101 |
| Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. | Molecular cancer 20080101 |
| Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor. | PloS one 20080101 |
| Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes. | Pathobiology : journal of immunopathology, molecular and cellular biology 20080101 |
| Severe prolonged immunosuppression following fludarabine and rituximab combination therapy. | Chemotherapy 20080101 |
| HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. | PloS one 20080101 |
| Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia. | Anticancer research 20080101 |
| Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report. | Journal of medical case reports 20080101 |
| Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. | BMC cancer 20080101 |
| Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report. | Cases journal 20080101 |
| High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus. | Chemotherapy 20080101 |
| Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. | Immunology and cell biology 20080101 |
| Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports. | Cases journal 20080101 |
| Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. | American journal of clinical dermatology 20080101 |
| Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia. | European journal of dermatology : EJD 20080101 |
| Disease-specific complications of chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20080101 |
| Current status of haploidentical stem cell transplantation for leukemia. | Journal of hematology & oncology 20080101 |
| Fludarabine in lymphoproliferative malignancies: a single-centre experience. | The National medical journal of India 20080101 |
| Extravasational side effects of cytotoxic drugs: A preventable catastrophe. | Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20080101 |
| Magnetic resonance imaging may simulate progressive multifocal leucoencephalopathy in a patient with chronic lymphocytic leukemia after fludarabine therapy. | Annals of Indian Academy of Neurology 20080101 |
| Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia. | The Egyptian journal of immunology 20080101 |
| Acute thrombosis in superior mesenteric artery as first symptom in a AML patient. | International journal of general medicine 20080101 |
| Experimental antioxidant therapy in ataxia telangiectasia. | Clinical medicine. Oncology 20080101 |
| T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. | Blood 20071215 |
| Have we forgotten the purpose of phase III studies? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210 |
| Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning. | Leukemia 20071201 |
| Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients. | American journal of hematology 20071201 |
| Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20071201 |
| Recent progress in the management of chronic lymphocytic leukemia. | Cancer treatment reviews 20071201 |
| Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. | Archives of biochemistry and biophysics 20071201 |
| Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201 |
| Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo. | European journal of haematology 20071201 |
| Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201 |
| Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201 |
| Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials. | Onkologie 20071201 |
| Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes. | Leukemia & lymphoma 20071201 |
| Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20071201 |
| [Effects of FLAG protocol in treatment of the first time induced non-remission acute myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20071201 |
| Clofarabine: new drug. Children with acute lymphoblastic leukaemia: a last resort. | Prescrire international 20071201 |
| Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia. | Journal of Korean medical science 20071201 |
| Switching of donor cells after urgent second cord blood transplantation for suspected graft failure. | International journal of hematology 20071201 |
| Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. | International journal of hematology 20071201 |
| What is the optimal initial treatment for chronic lymphocytic leukemia? | Oncology (Williston Park, N.Y.) 20071201 |
| Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. | Therapeutics and clinical risk management 20071201 |
| Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. | Cancer research 20071115 |
| Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia. | Blood 20071101 |
| Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan. | Bone marrow transplantation 20071101 |
| Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. | Bone marrow transplantation 20071101 |
| Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. | British journal of haematology 20071101 |
| Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. | Bone marrow transplantation 20071101 |
| Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. | British journal of haematology 20071101 |
| Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101 |
| Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis. | Experimental hematology 20071101 |
| Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. | British journal of haematology 20071101 |
| [MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland]. | Journal francais d'ophtalmologie 20071101 |
| Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG). | International journal of hematology 20071101 |
| [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment]. | Vnitrni lekarstvi 20071101 |
| Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. | Blood 20071015 |
| Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens. | Blood 20071015 |
| Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia. | Leukemia 20071001 |
| Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan. | American journal of hematology 20071001 |
| Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. | Blood 20071001 |
| Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. | Blood 20071001 |
| Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial. | American journal of hematology 20071001 |
| Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan. | Leukemia 20071001 |
| Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome. | Journal of inherited metabolic disease 20071001 |
| Transplantation tolerance: lessons from experimental rodent models. | Transplant international : official journal of the European Society for Organ Transplantation 20071001 |
| Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia. | Haematologica 20071001 |
| Clofarabine: past, present, and future. | Leukemia & lymphoma 20071001 |
| Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. | British journal of haematology 20071001 |
| Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma. | British journal of haematology 20071001 |
| A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases. | British journal of haematology 20071001 |
| High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071001 |
| Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. | Hematology (Amsterdam, Netherlands) 20071001 |
| Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy. | Leukemia & lymphoma 20071001 |
| The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy. | Leukemia & lymphoma 20071001 |
| Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia. | Leukemia & lymphoma 20071001 |
| Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. | The Netherlands journal of medicine 20071001 |
| [Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20071001 |
| [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice]. | Zhongguo shi yan xue ye xue za zhi 20071001 |
| Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia. | International journal of hematology 20071001 |
| The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. | Haematologica 20071001 |
| Oblimersen for the treatment of patients with chronic lymphocytic leukemia. | Therapeutics and clinical risk management 20071001 |
| Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia. | The Medical journal of Malaysia 20071001 |
| Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma. | Current hematologic malignancy reports 20071001 |
| Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin. | Transplantation 20070915 |
| Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. | British journal of cancer 20070911 |
| R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells. | Cancer chemotherapy and pharmacology 20070901 |
| Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs. | Gene therapy 20070901 |
| Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. | Bone marrow transplantation 20070901 |
| Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study. | Bone marrow transplantation 20070901 |
| New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. | Bone marrow transplantation 20070901 |
| Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070901 |
| Chemoimmunotherapy of chronic lymphocytic leukemia. | Best practice & research. Clinical haematology 20070901 |
| Minimal residual disease assessment in chronic lymphocytic leukaemia. | Best practice & research. Clinical haematology 20070901 |
| Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). | Pediatric hematology and oncology 20070901 |
| CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. | British journal of haematology 20070901 |
| Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells. | Haematologica 20070901 |
| Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome. | The Ulster medical journal 20070901 |
| Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia. | Cancer genetics and cytogenetics 20070901 |
| B-lymphocytes as targets for therapy in chronic cold agglutinin disease. | Cardiovascular & hematological disorders drug targets 20070901 |
| Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults. | The American journal of geriatric pharmacotherapy 20070901 |
| Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues. | Experimental oncology 20070901 |
| [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070901 |
| Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects. | Biologics : targets & therapy 20070901 |
| Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. | Oncogene 20070823 |
| Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. | Blood 20070815 |
| Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. | Transplantation 20070815 |
| Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine. | Annals of hematology 20070801 |
| Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. | Annals of hematology 20070801 |
| Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. | Bone marrow transplantation 20070801 |
| Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes. | British journal of haematology 20070801 |
| Alkylator-free conditioning regimen for patients with acquired aplastic anemia, transplanted from genetically identical twins. | Pediatric transplantation 20070801 |
| The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. | Transfusion 20070801 |
| Regurgitation of esophageal mucosa. | Mayo Clinic proceedings 20070801 |
| Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine. | Leukemia & lymphoma 20070801 |
| Combination therapies for previously untreated CLL. | Lancet (London, England) 20070721 |
| Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. | Lancet (London, England) 20070721 |
| Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. | British journal of cancer 20070716 |
| Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation. | International journal of radiation oncology, biology, physics 20070715 |
| T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. | Leukemia research 20070701 |
| Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. | Bone marrow transplantation 20070701 |
| Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. | Bone marrow transplantation 20070701 |
| Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20070701 |
| Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients. | Bone marrow transplantation 20070701 |
| A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells. | Leukemia 20070701 |
| Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma. | Cancer 20070701 |
| Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning. | Bone marrow transplantation 20070701 |
| Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701 |
| Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701 |
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. | Experimental hematology 20070701 |
| Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients. | British journal of haematology 20070701 |
| Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor. | International journal of hematology 20070701 |
| [Bone marrow-restricted involvement of T-cell granular lymphocyte leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20070701 |
| Chemotherapy for myeloid malignancy in children with Fanconi anemia. | Pediatric blood & cancer 20070615 |
| Dictyostelium discoideum salvages purine deoxyribonucleosides by highly specific bacterial-like deoxyribonucleoside kinases. | Journal of molecular biology 20070608 |
| A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours. | British journal of cancer 20070604 |
| Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma. | Annals of the rheumatic diseases 20070601 |
| Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism. | American journal of hematology 20070601 |
| Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models. | Cancer chemotherapy and pharmacology 20070601 |
| Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia. | Blood 20070601 |
| Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. | American journal of physiology. Heart and circulatory physiology 20070601 |
| Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis. | Rheumatology (Oxford, England) 20070601 |
| Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine. | International journal of oncology 20070601 |
| Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070601 |
| Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience. | Hematology (Amsterdam, Netherlands) 20070601 |
| The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome. | International journal of hematology 20070601 |
| Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. | Leukemia & lymphoma 20070601 |
| Alemtuzumab in chronic lymphocytic leukemia. | Current oncology (Toronto, Ont.) 20070601 |
| [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20070601 |
| [Chronic lymphoid leukemia and intravenous immunoglobulins]. | La Revue de medecine interne 20070601 |
| Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma. | Biologics : targets & therapy 20070601 |
| Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. | Oncogene 20070528 |
| Management of symptomatic, untreated chronic lymphocytic leukemia. | Blood reviews 20070501 |
| Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay. | Cytometry. Part B, Clinical cytometry 20070501 |
| Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines. | Cancer chemotherapy and pharmacology 20070501 |
| Allogeneic bone marrow transplantation for Pearson's syndrome. | Bone marrow transplantation 20070501 |
| Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway. | Leukemia 20070501 |
| Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501 |
| Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. | Oncology reports 20070501 |
| A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia. | Journal of the American Academy of Dermatology 20070501 |
| A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070501 |
| Immunodeficiency-related Hodgkin lymphoma and its mimics. | Advances in anatomic pathology 20070501 |
| Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. | British journal of haematology 20070501 |
| In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation. | International journal of hematology 20070501 |
| Immunomodulatory drugs in chronic lymphocytic leukemia: a new treatment paradigm. | Leukemia & lymphoma 20070501 |
| Acquired hemophilia in chronic lymphocytic leukemia. | Leukemia & lymphoma 20070501 |
| Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. | Haematologica 20070501 |
| Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). | Haematologica 20070501 |
| [Ulcers in a patient with chronic lymphocytic leukemia]. | Actas dermo-sifiliograficas 20070501 |
| Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced. | The Netherlands journal of medicine 20070501 |
| Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas. | Cancer chemotherapy and pharmacology 20070401 |
| Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein. | Cancer immunology, immunotherapy : CII 20070401 |
| Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401 |
| Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. | Bone marrow transplantation 20070401 |
| Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases. | Bone marrow transplantation 20070401 |
| Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma. | European journal of haematology 20070401 |
| Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401 |
| Current treatment options in prolymphocytic leukemia. | Medical science monitor : international medical journal of experimental and clinical research 20070401 |
| Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia. | Infection 20070401 |
| Gene expression signatures that predict radiation exposure in mice and humans. | PLoS medicine 20070401 |
| Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning. | Journal of Korean medical science 20070401 |
| Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. | Hematology (Amsterdam, Netherlands) 20070401 |
| Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma. | Leukemia & lymphoma 20070401 |
| Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation. | International journal of hematology 20070401 |
| Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. | Haematologica 20070401 |
| Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx. | The Annals of otology, rhinology, and laryngology 20070401 |
| Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes. | Current treatment options in oncology 20070401 |
| Splenic marginal zone lymphoma with and without villous lymphocytes. | Current treatment options in oncology 20070401 |
| Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320 |
| Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours. | British journal of cancer 20070312 |
| Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia. | Leukemia research 20070301 |
| Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. | Blood 20070301 |
| Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). | Leukemia 20070301 |
| Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy. | Leukemia 20070301 |
| Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. | Cancer gene therapy 20070301 |
| Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia. | Clinical and experimental dermatology 20070301 |
| Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301 |
| Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301 |
| Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients. | Transplant infectious disease : an official journal of the Transplantation Society 20070301 |
| Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301 |
| Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation. | Haematologica 20070301 |
| Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. | British journal of haematology 20070301 |
| Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. | Leukemia & lymphoma 20070301 |
| Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? | Leukemia research 20070201 |
| Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia. | Leukemia research 20070201 |
| F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan. | Bone marrow transplantation 20070201 |
| Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. | Bone marrow transplantation 20070201 |
| Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. | Bone marrow transplantation 20070201 |
| Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation. | Onkologie 20070201 |
| Alemtuzumab in chronic lymphocytic leukemia. | Future oncology (London, England) 20070201 |
| Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? | European journal of haematology 20070201 |
| Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings. | European journal of haematology 20070201 |
| Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells. | International journal of hematology 20070201 |
| 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. | Leukemia & lymphoma 20070201 |
| Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review. | Leukemia & lymphoma 20070201 |
| Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. | Haematologica 20070201 |
| Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient. | Leukemia research 20070101 |
| Preclinical assessment of curcumin as a potential therapy for B-CLL. | American journal of hematology 20070101 |
| Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. | Blood 20070101 |
| Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. | Annals of hematology 20070101 |
| STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. | International journal of cancer 20070101 |
| Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. | British journal of haematology 20070101 |
| Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. | Journal of the American Academy of Dermatology 20070101 |
| Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia. | Bone marrow transplantation 20070101 |
| Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages. | Shock (Augusta, Ga.) 20070101 |
| Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation. | Journal of clinical pharmacology 20070101 |
| Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. | British journal of haematology 20070101 |
| Double unrelated reduced-intensity umbilical cord blood transplantation in adults. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070101 |
| Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. | Orphanet journal of rare diseases 20070101 |
| Cord blood in regenerative medicine: do we need immune suppression? | Journal of translational medicine 20070101 |
| Improved outcome after relapse in children with acute myeloid leukaemia. | British journal of haematology 20070101 |
| Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma. | European journal of dermatology : EJD 20070101 |
| Advances in CLL. | Clinical advances in hematology & oncology : H&O 20070101 |
| Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells. | PloS one 20070101 |
| Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients. | Acta haematologica 20070101 |
| Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. | Haematologica 20070101 |
| Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia. | Haematologica 20070101 |
| A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII. | Molecular cancer 20070101 |
| Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101 |
| Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. | Journal of nanobiotechnology 20070101 |
| Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy. | BMC nephrology 20070101 |
| [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?]. | Revista de medicina de la Universidad de Navarra 20070101 |
| Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20070101 |
| Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101 |
| Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia. | Anticancer research 20070101 |
| Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report. | Journal of medical case reports 20070101 |
| Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. | Genome biology 20070101 |
| Fludarabine: a review of its use in non-Hodgkin's lymphoma. | Drugs 20070101 |
| Paraneoplastic pemphigus associated with fludarabine use. | Medical oncology (Northwood, London, England) 20070101 |
| [Visual cortes--is it a concern?]. | Bulletin de la Societe belge d'ophtalmologie 20070101 |
| Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium. | Drugs in R&D 20070101 |
| [Allogenic transplantation of hemopoietic stem cells in low-intensity regimes in patients with hematological malignancies]. | Terapevticheskii arkhiv 20070101 |
| [Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide]. | Terapevticheskii arkhiv 20070101 |
| Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response. | Journal of translational medicine 20070101 |
| Economic evaluation of third-line treatment with alemtuzumab for chronic lymphocytic leukaemia. | Clinical drug investigation 20070101 |
| Chronic lymphocytic leukemia masquerading as uveitis. | Retina (Philadelphia, Pa.) 20070101 |
| The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin. | Asian Pacific journal of cancer prevention : APJCP 20070101 |
| IPEX as a result of mutations in FOXP3. | Clinical & developmental immunology 20070101 |
| Rituximab maintenance in relapsed or refractory follicular non-Hodgkin's lymphoma: the evidence of its therapeutic value. | Core evidence 20070101 |
| Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature. | The Libyan journal of medicine 20070101 |
| Targeting receptors, transporters and site of absorption to improve oral drug delivery. | Drug target insights 20070101 |
| Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). | Blood 20061215 |
| Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. | Blood 20061215 |
| Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy. | Neurology 20061212 |
| Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. | Leukemia research 20061201 |
| Chronic lymphocytic leukaemia Is terminal del(14)(q24) a new marker for prognostic stratification? | Leukemia research 20061201 |
| Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods. | American journal of physiology. Cell physiology 20061201 |
| High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients. | American journal of hematology 20061201 |
| Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen. | Bone marrow transplantation 20061201 |
| Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201 |
| Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? | Nature clinical practice. Oncology 20061201 |
| Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. | Haematologica 20061201 |
| Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. | Experimental hematology 20061201 |
| Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201 |
| Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201 |
| Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20061201 |
| Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma. | Haematologica 20061201 |
| Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia. | The Yale journal of biology and medicine 20061201 |
| Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes. | Therapeutics and clinical risk management 20061201 |
| Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys. | Journal of controlled release : official journal of the Controlled Release Society 20061128 |
| CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53. | Blood 20061115 |
| Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging. | Cancer chemotherapy and pharmacology 20061101 |
| Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens. | British journal of haematology 20061101 |
| Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine. | Pediatric transplantation 20061101 |
| Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. | European journal of haematology 20061101 |
| Treatment-related myelodysplasia following fludarabine combination chemotherapy. | Haematologica 20061101 |
| Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061101 |
| Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061101 |
| Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. | Leukemia & lymphoma 20061101 |
| Chronic lymphocytic leukemia: current and emerging treatment approaches. | Clinical advances in hematology & oncology : H&O 20061101 |
| Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. | Transplantation 20061015 |
| Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). | Annals of hematology 20061001 |
| Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen. | European journal of haematology 20061001 |
| The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. | British journal of haematology 20061001 |
| Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes. | British journal of haematology 20061001 |
| Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation. | Bone marrow transplantation 20061001 |
| Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia. | Bone marrow transplantation 20061001 |
| Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. | Cancer research 20061001 |
| Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061001 |
| Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061001 |
| Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study. | Archives of Iranian medicine 20061001 |
| Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001 |
| New directions in the treatment of mantle cell lymphoma: an overview. | Clinical lymphoma & myeloma 20061001 |
| [T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome]. | Zeitschrift fur Rheumatologie 20060901 |
| Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia. | Cancer 20060901 |
| Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. | Bone marrow transplantation 20060901 |
| Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations. | Journal of viral hepatitis 20060901 |
| Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060901 |
| High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication. | Annals of oncology : official journal of the European Society for Medical Oncology 20060901 |
| Role of fludarabine in hematological malignancies. | Expert review of anticancer therapy 20060901 |
| Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20060901 |
| Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. | Leukemia & lymphoma 20060901 |
| Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20060901 |
| Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. | International journal of nanomedicine 20060901 |
| Nelarabine: a new purine analog in the treatment of hematologic malignancies. | Reviews on recent clinical trials 20060901 |
| Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. | Blood 20060815 |
| The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders. | Cancer 20060815 |
| A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia. | British journal of cancer 20060807 |
| Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. | Blood 20060801 |
| Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. | Blood 20060801 |
| Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. | Bone marrow transplantation 20060801 |
| Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine. | Journal of medical virology 20060801 |
| Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis. | Cancer treatment reviews 20060801 |
| Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning. | Bone marrow transplantation 20060801 |
| Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece. | Journal of medical microbiology 20060801 |
| A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801 |
| Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801 |
| Fludarabine in chronic lymphocytic leukaemia. | Expert opinion on pharmacotherapy 20060801 |
| Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia. | Archives of pathology & laboratory medicine 20060801 |
| In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia. | Cancer biotherapy & radiopharmaceuticals 20060801 |
| MicroRNAs in leukemia. | Clinical advances in hematology & oncology : H&O 20060801 |
| Purine antagonists for chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20060719 |
| Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. | European journal of haematology 20060701 |
| An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060701 |
| Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701 |
| Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701 |
| Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT. | Experimental hematology 20060701 |
| Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060701 |
| Subcutaneous Taenia crassiceps infection in a patient with non-Hodgkin's lymphoma. | The American journal of tropical medicine and hygiene 20060701 |
| Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. | British journal of haematology 20060701 |
| High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders. | British journal of haematology 20060701 |
| [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701 |
| Reduced-intensity transplantation for lymphoma. | Current treatment options in oncology 20060701 |
| Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment. | Leukemia & lymphoma 20060701 |
| Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma. | British journal of cancer 20060619 |
| Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. | Blood 20060615 |
| A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. | European journal of haematology 20060601 |
| Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma. | Cancer 20060601 |
| Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone. | American journal of hematology 20060601 |
| Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy. | American journal of hematology 20060601 |
| Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. | Journal of the American Society of Nephrology : JASN 20060601 |
| Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma. | British journal of haematology 20060601 |
| Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. | British journal of haematology 20060601 |
| Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060601 |
| A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients. | Haematologica 20060601 |
| Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma. | Onkologie 20060601 |
| Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. | International journal of hematology 20060601 |
| Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601 |
| [Waldemström s macroglobulinemia]. | Anales de medicina interna (Madrid, Spain : 1984) 20060601 |
| Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors. | Hematology (Amsterdam, Netherlands) 20060601 |
| Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome. | Hematology (Amsterdam, Netherlands) 20060601 |
| Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer. | British journal of cancer 20060522 |
| Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520 |
| Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). | Blood 20060515 |
| MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. | Blood 20060515 |
| Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. | Pediatric blood & cancer 20060501 |
| DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells. | Leukemia 20060501 |
| Fludarabine induces pro-inflammatory activation of human monocytic cells through a MAPK/ERK pathway. | International immunopharmacology 20060501 |
| Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders. | Bone marrow transplantation 20060501 |
| New agents in chronic lymphocytic leukemia. | Current treatment options in oncology 20060501 |
| Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. | British journal of haematology 20060501 |
| Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor. | International journal of hematology 20060501 |
| Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning. | International journal of hematology 20060501 |
| Unusual cutaneous manifestation of angiocentric T-cell lymphoma: a case report. | Cutis 20060501 |
| t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. | Cancer 20060415 |
| The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative. | The Journal of biological chemistry 20060414 |
| Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. | Gene 20060412 |
| Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. | Journal of cellular physiology 20060401 |
| Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. | Leukemia research 20060401 |
| Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. | Bone marrow transplantation 20060401 |
| Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401 |
| The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia. | Haematologica 20060401 |
| Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401 |
| Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401 |
| The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. | Seminars in hematology 20060401 |
| Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia. | Seminars in hematology 20060401 |
| Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia. | Seminars in hematology 20060401 |
| Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis. | American journal of hematology 20060401 |
| The infectious consequences of rituximab addition to fludarabine-containing regimens. | Blood 20060401 |
| Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401 |
| Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401 |
| High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia. | British journal of haematology 20060401 |
| Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. | Journal of Korean medical science 20060401 |
| Clinical characteristics and outcomes of posttransplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation in Korea. | Journal of Korean medical science 20060401 |
| Richter's transformation in chronic lymphocytic leukemia. | Seminars in oncology 20060401 |
| Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060401 |
| Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection. | Journal of pediatric hematology/oncology 20060401 |
| [State of the art in the treatment of chronic leukemias]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060401 |
| Beyond detectable minimal residual disease in chronic lymphocytic leukemia. | Seminars in oncology 20060401 |
| Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. | Transplantation 20060327 |
| PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes. | Chemico-biological interactions 20060325 |
| Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy. | Spinal cord 20060301 |
| Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies. | Bone marrow transplantation 20060301 |
| Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect. | Bone marrow transplantation 20060301 |
| Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. | Cancer 20060301 |
| Transplant strategies for patients with myelodysplastic syndromes. | Current opinion in hematology 20060301 |
| Positron emission tomography--positive distal femur following fludarabine, dexamethasone and mitoxantrone chemotherapy. | British journal of haematology 20060301 |
| Guidelines on the management of Waldenström macroglobulinaemia. | British journal of haematology 20060301 |
| Exacerbation of chronic epidural abscess following a fludarabine-based preparative regimen. | American journal of hematology 20060301 |
| Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience. | American journal of hematology 20060301 |
| Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060301 |
| Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060301 |
| Emerging drugs for chronic lymphocytic leukaemia. | Expert opinion on emerging drugs 20060301 |
| Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies. | Clinical and experimental medicine 20060301 |
| [Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20060301 |
| F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. | Nucleosides, nucleotides & nucleic acids 20060301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060301 |
| Advances in the treatment of chronic lymphocytic leukemia. | Current hematologic malignancy reports 20060301 |
| Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. | Blood 20060215 |
| Monoclonal antibody therapy of chronic lymphocytic leukemia. | Cancer immunology, immunotherapy : CII 20060201 |
| Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. | Blood 20060201 |
| Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. | Blood 20060201 |
| Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. | Leukemia 20060201 |
| Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. | Bone marrow transplantation 20060201 |
| Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma. | Cancer 20060201 |
| Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning. | Bone marrow transplantation 20060201 |
| Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer. | Bone marrow transplantation 20060201 |
| Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion. | European journal of haematology 20060201 |
| Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). | Bone marrow transplantation 20060201 |
| Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. | Bone marrow transplantation 20060201 |
| The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation. | Acta crystallographica. Section D, Biological crystallography 20060201 |
| Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. | Clinical and laboratory haematology 20060201 |
| Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201 |
| Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201 |
| Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation. | Journal of Korean medical science 20060201 |
| Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia. | Apoptosis : an international journal on programmed cell death 20060201 |
| Successful reduced-intensity hematopoietic stem cell transplantation in myelodysplastic syndrome with severe coronary artery disease. | International journal of hematology 20060201 |
| Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma. | Military medicine 20060201 |
| [The outcomes of the thirty patients with refractory leukemia treated with related HLA haploidentical stem cells transplantation]. | Zhonghua nei ke za zhi 20060201 |
| [Effect of inhibitors of signal transducer and activator of transcription-1/3 on expression of tumor necrosis factor-alpha induced by high mobility group box-1 protein inflammatory response in rat peritoneal macrophages]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20060201 |
| Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens. | Cancer 20060115 |
| Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. | Blood 20060101 |
| Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. | Drug metabolism and disposition: the biological fate of chemicals 20060101 |
| A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems. | Molecular pharmacology 20060101 |
| Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. | Leukemia 20060101 |
| Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan. | Leukemia & lymphoma 20060101 |
| Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101 |
| Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study. | European journal of haematology 20060101 |
| PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. | British journal of haematology 20060101 |
| Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia. | Transfusion 20060101 |
| The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060101 |
| Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience. | Japanese journal of clinical oncology 20060101 |
| Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study. | Acta haematologica 20060101 |
| Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060101 |
| In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. | Haematologica 20060101 |
| Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. | International journal of hematology 20060101 |
| Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia. | JPMA. The Journal of the Pakistan Medical Association 20060101 |
| [Allogeneic stem cell transplantation with fludarabine/melphalan (non-TBI and non-BU/CY) for patients aged 50 or more]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060101 |
| Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. | BMC infectious diseases 20060101 |
| Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| [Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine]. | Enfermedades infecciosas y microbiologia clinica 20060101 |
| [Allogeneic transplantation of peripheral blood hematopoietic stem-cells with low intensity conditioning for the treatment of a metastatic clear cell carcinoma. Preliminary results after two years of follow-up]. | Archivos espanoles de urologia 20060101 |
| Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20060101 |
| Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia. | BMC cancer 20060101 |
| [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report]. | Lijecnicki vjesnik 20060101 |
| Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases. | Journal of biomedicine & biotechnology 20060101 |
| JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages. | Mediators of inflammation 20060101 |
| Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine. | Nucleosides, nucleotides & nucleic acids 20060101 |
| [Remission in T-cell prolymphocytic leukemia during the FMC treatment course]. | Terapevticheskii arkhiv 20060101 |
| IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience. | American journal of therapeutics 20060101 |
| High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission. | Medical oncology (Northwood, London, England) 20060101 |
| Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues. | Nucleosides, nucleotides & nucleic acids 20060101 |
| A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation. | BMC infectious diseases 20060101 |
| Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. | Journal of carcinogenesis 20060101 |
| Current and investigational therapies for patients with CLL. | Hematology. American Society of Hematology. Education Program 20060101 |
| Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies. | Hematology. American Society of Hematology. Education Program 20060101 |
| Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. | Current medicinal chemistry 20060101 |
| Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101 |
| Radioimmunotherapy: a brief overview. | Biomedical imaging and intervention journal 20060101 |
| Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. | Blood 20051215 |
| The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia. | Cancer 20051215 |
| The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. | British journal of cancer 20051212 |
| OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action. | Journal of the National Cancer Institute 20051207 |
| Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. | Pediatric blood & cancer 20051201 |
| Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. | Bone marrow transplantation 20051201 |
| Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. | Bone marrow transplantation 20051201 |
| Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. | Leukemia & lymphoma 20051201 |
| Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. | European journal of haematology 20051201 |
| Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen. | Clinical transplantation 20051201 |
| Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review. | Expert opinion on pharmacotherapy 20051201 |
| Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051201 |
| Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. | Haematologica 20051201 |
| [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma]. | Ai zheng = Aizheng = Chinese journal of cancer 20051201 |
| Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot. | International journal of clinical pharmacology and therapeutics 20051201 |
| Significance of VH genes mutation status for prognosis of CLL patients. | Experimental oncology 20051201 |
| [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20051201 |
| [The role of Janus kinase-signal transducer and transcription activator pathway in the regulation of synthesis and release of lipopolysaccharide-induced high mobility group box-1 protein]. | Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 20051201 |
| Microbiologic consequences of new approaches to managing hematologic malignancies. | Reviews in clinical and experimental hematology 20051201 |
| Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1. | British journal of cancer 20051128 |
| Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL). | Blood 20051115 |
| An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning. | Transplantation 20051115 |
| Engineering T cells for cancer therapy. | British journal of cancer 20051114 |
| Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity. | Leukemia research 20051101 |
| Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT. | Blood 20051101 |
| Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. | Blood 20051101 |
| FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. | Annals of hematology 20051101 |
| Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation. | Bone marrow transplantation 20051101 |
| Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment. | Cancer 20051101 |
| Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706. | Leukemia 20051101 |
| Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia. | Leukemia & lymphoma 20051101 |
| Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding study. | European journal of cancer (Oxford, England : 1990) 20051101 |
| The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. | Haematologica 20051101 |
| Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor. | International journal of hematology 20051101 |
| Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma. | Clinical lymphoma & myeloma 20051101 |
| [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20051101 |
| [Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20051101 |
| [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia]. | Fukuoka igaku zasshi = Hukuoka acta medica 20051101 |
| Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020 |
| Richter's syndrome--the downside of fludarabine? | Leukemia research 20051001 |
| Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. | Leukemia research 20051001 |
| Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients. | Leukemia 20051001 |
| Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). | International journal of oncology 20051001 |
| Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001 |
| Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine. | Japanese journal of clinical oncology 20051001 |
| Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. | British journal of haematology 20051001 |
| High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML. | Therapeutic drug monitoring 20051001 |
| Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051001 |
| Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. | British journal of haematology 20051001 |
| Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. | British journal of haematology 20051001 |
| Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051001 |
| Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma. | Haematologica 20051001 |
| Alemtuzumab (Campath 1-H). | Clinical journal of oncology nursing 20051001 |
| Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. | International journal of clinical oncology 20051001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051001 |
| [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]. | Deutsche medizinische Wochenschrift (1946) 20050923 |
| Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920 |
| Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. | Blood 20050915 |
| A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group. | Annals of hematology 20050901 |
| Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. | Blood 20050901 |
| Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia. | Bone marrow transplantation 20050901 |
| Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia--experience in a single UK centre. | Bone marrow transplantation 20050901 |
| Advances in the treatment of chronic lymphocytic leukemia. | Current oncology reports 20050901 |
| Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. | Leukemia & lymphoma 20050901 |
| 'Specific' cutaneous infiltrate of B-cell chronic lymphocytic leukemia at the site of a florid herpes simplex infection. | Journal of cutaneous pathology 20050901 |
| Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. | British journal of haematology 20050901 |
| Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications. | Current cancer drug targets 20050901 |
| Successful nonmyeloablative cord blood transplantation for an infant with malignant infantile osteopetrosis. | Journal of pediatric hematology/oncology 20050901 |
| Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20050901 |
| [Pulmonary tuberculosis and adenovirus-hemorrhagic cystitis after autologous peripheral blood stem cell transplantation for follicular lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20050901 |
| P2X(7) receptor: Death or life? | Purinergic signalling 20050901 |
| Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. | British journal of cancer 20050822 |
| [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia]. | Orvosi hetilap 20050821 |
| Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| [Treatment of refractory and relapsed acute lymphocytic leukemia in adults]. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050818 |
| Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. | Blood 20050801 |
| Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. | Bone marrow transplantation 20050801 |
| Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050801 |
| Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. | American journal of hematology 20050801 |
| Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. | Haematologica 20050801 |
| 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study. | British journal of haematology 20050801 |
| [Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning]. | Zhongguo shi yan xue ye xue za zhi 20050801 |
| [Treatment of thalassemia major with unrelated donor bone marrow transplantation]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20050801 |
| The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. | Blood 20050715 |
| Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen. | Cancer 20050715 |
| Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. | Transplantation 20050715 |
| Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment. | Annals of hematology 20050701 |
| An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation. | Japanese journal of clinical oncology 20050701 |
| Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: case report and review of literature. | American journal of hematology 20050701 |
| Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701 |
| Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients. | International journal of dermatology 20050701 |
| [Auto-immune manifestations in Non-Hodgkin's lymphoma]. | La Revue de medecine interne 20050701 |
| Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis. | Microbes and infection 20050701 |
| Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia. | Leukemia & lymphoma 20050701 |
| Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia. | Leukemia & lymphoma 20050701 |
| Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation. | British journal of haematology 20050701 |
| Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. | PLoS genetics 20050701 |
| Pulmonary non-caseating granuloma in Waldenström macroglobulinemia. | The Tokai journal of experimental and clinical medicine 20050701 |
| [Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20050701 |
| A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050625 |
| Changing the way we think about chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620 |
| Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. | Blood 20050615 |
| Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. | Transplantation 20050615 |
| Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. | Biochemical and biophysical research communications 20050603 |
| A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. | Blood 20050601 |
| Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. | Blood 20050601 |
| Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. | Leukemia 20050601 |
| Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601 |
| CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors. | Bone marrow transplantation 20050601 |
| Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation. | European journal of haematology 20050601 |
| Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. | European journal of haematology 20050601 |
| Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia. | Cancer treatment reviews 20050601 |
| Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. | British journal of haematology 20050601 |
| Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050601 |
| Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050601 |
| Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601 |
| Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601 |
| An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment. | Clinical and laboratory haematology 20050601 |
| Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature. | Annals of diagnostic pathology 20050601 |
| Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia. | Haematologica 20050601 |
| Economic assessment on the management of chronic lymphocytic leukaemia. | Expert opinion on pharmacotherapy 20050601 |
| The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma. | Clinical lymphoma 20050601 |
| FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study. | JPMA. The Journal of the Pakistan Medical Association 20050601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050601 |
| Apoptosis of peripheral human blood lymphocytes induced by physical-chemical influences and generation of reactive oxygen species. | Annals of the New York Academy of Sciences 20050601 |
| Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues. | International journal of hematology 20050601 |
| Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report. | International journal of hematology 20050601 |
| Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520 |
| Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. | Blood 20050515 |
| The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog. | Cancer 20050515 |
| Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity. | European journal of pharmacology 20050509 |
| Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality. | Annals of hematology 20050501 |
| Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. | Bone marrow transplantation 20050501 |
| High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. | Leukemia 20050501 |
| Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. | Bone marrow transplantation 20050501 |
| Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution. | Bone marrow transplantation 20050501 |
| In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells. | European journal of haematology 20050501 |
| Symmetric bony involvement of the lower extremities with lymphoma demonstrated on gallium scintigraphy. | Clinical nuclear medicine 20050501 |
| Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation. | British journal of haematology 20050501 |
| Prolymphocytic leukemia. | Current treatment options in oncology 20050501 |
| Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. | Haematologica 20050501 |
| Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. | Haematologica 20050501 |
| Haematopoietic stem cell transplantation to treat aplastic anaemia. | Expert opinion on biological therapy 20050501 |
| Successful reduced-intensity stem cell transplantation (RIST) for a patient with malignant lymphoma and an ileostomy. | Internal medicine (Tokyo, Japan) 20050501 |
| [Nonmyleoablative allogeneic stem cell transplantation combined with imatinib in treatment of chronic myeloid leukemia: a clinical study]. | Zhonghua yi xue za zhi 20050427 |
| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. | Blood 20050415 |
| Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation. | Transplantation 20050415 |
| Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20050401 |
| Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine. | Annals of hematology 20050401 |
| Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050401 |
| Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. | Leukemia research 20050401 |
| Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. | Bone marrow transplantation 20050401 |
| AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway. | Leukemia 20050401 |
| Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. | European journal of haematology 20050401 |
| HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism. | Clinical and laboratory haematology 20050401 |
| Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF. | Bone marrow transplantation 20050401 |
| Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV. | British journal of haematology 20050401 |
| HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050401 |
| Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050401 |
| Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. | British journal of haematology 20050401 |
| Five-month marrow aplasia in a child with refractory acute myeloid leukemia: successful management with continuous granulocyte support and reduced-intensity conditioning followed by matched unrelated bone marrow transplantation. | Journal of pediatric hematology/oncology 20050401 |
| [Clinical study on transplantation of G-CSF-mobilized allo-PBSC and allo-bone marrow for leukemia patients]. | Zhongguo shi yan xue ye xue za zhi 20050401 |
| Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin. | Stem cells and development 20050401 |
| Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP. | Leukemia & lymphoma 20050401 |
| Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. | Transplantation 20050327 |
| Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050320 |
| Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. | Blood 20050315 |
| An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. | British journal of cancer 20050314 |
| Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB. | The Journal of biological chemistry 20050311 |
| Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. | Blood 20050301 |
| Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20050301 |
| Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. | Bone marrow transplantation 20050301 |
| Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. | Bone marrow transplantation 20050301 |
| Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. | Leukemia 20050301 |
| Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin? | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies. | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia. | Anti-cancer drugs 20050301 |
| Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning. | British journal of haematology 20050301 |
| Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis. | British journal of haematology 20050301 |
| Innovations in antineoplastic therapy. | The Nursing clinics of North America 20050301 |
| Diagnosis and management of Waldenstrom's macroglobulinemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301 |
| Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvement. | Archives of pathology & laboratory medicine 20050301 |
| Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia. | Journal of pediatric hematology/oncology 20050301 |
| Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050301 |
| Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation. | Bone marrow transplantation 20050301 |
| [Current and new therapeutic strategies in acute myeloid leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050301 |
| CHOP plus rituximab therapy in Waldenstrom's macroglobulinemia. | Clinical lymphoma 20050301 |
| Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia. | Clinical lymphoma 20050301 |
| Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders. | Clinical lymphoma 20050301 |
| Hematopoietic transplantation for bone marrow failure syndromes and thalassemia. | Bone marrow transplantation 20050301 |
| [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]. | Bulletin du cancer 20050301 |
| [News in therapeutic management of chronic lymphoid leukemia]. | Bulletin du cancer 20050301 |
| [Umbilical cord blood transplantation for patients with beta-thalassemia major]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20050301 |
| High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. | International journal of cancer 20050220 |
| Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. | Blood 20050215 |
| Cardiac toxicity of high-dose chemotherapy. | Bone marrow transplantation 20050201 |
| Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience. | Bone marrow transplantation 20050201 |
| The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland. | Annals of hematology 20050201 |
| Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). | Bone marrow transplantation 20050201 |
| A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. | Bone marrow transplantation 20050201 |
| Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. | Bone marrow transplantation 20050201 |
| Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor. | Pediatric transplantation 20050201 |
| Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| The role of mitoxantrone in the treatment of indolent lymphomas. | The oncologist 20050201 |
| Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. | Haematologica 20050201 |
| Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis. | Haematologica 20050201 |
| Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia. | Stem cells and development 20050201 |
| Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence. | Prescrire international 20050201 |
| Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle cell lymphoma presenting in the leukemic phase. | International journal of hematology 20050201 |
| Lymphoma: diagnosis, staging, natural history, and treatment strategies. | Seminars in oncology 20050201 |
| Future trends in radioimmunotherapy. | Seminars in oncology 20050201 |
| Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations. | Blood 20050115 |
| Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. | Blood 20050101 |
| Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells. | Leukemia 20050101 |
| Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning. | Leukemia 20050101 |
| Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT. | Bone marrow transplantation 20050101 |
| Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. | Bone marrow transplantation 20050101 |
| Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20050101 |
| Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050101 |
| How we treat Waldenström's macroglobulinemia. | Haematologica 20050101 |
| Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine. | Haematologica 20050101 |
| Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells. | BMC cancer 20050101 |
| PNP with Waldenström's macroglobulinaemia. | Clinical and experimental dermatology 20050101 |
| Alemtuzumab in the treatment of chronic lymphocytic leukemia. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20050101 |
| Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia. | International journal of hematology 20050101 |
| Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). | The pharmacogenomics journal 20050101 |
| In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses. | Neoplasma 20050101 |
| Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication. | Cell biology international 20050101 |
| Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link? | Anticancer research 20050101 |
| Fludarabine phosphate may be useful in the treatment of graft-versus-host disease. | Medical hypotheses 20050101 |
| Lipid nucleoside conjugates for the treatment of cancer. | Current pharmaceutical design 20050101 |
| Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience. | Neoplasma 20050101 |
| Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. | BMC cancer 20050101 |
| Waldenström's macroglobulinemia. | Best practice & research. Clinical haematology 20050101 |
| Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice. | BMC cancer 20050101 |
| In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. | BMC cancer 20050101 |
| Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome. | Cancer investigation 20050101 |
| Primary and secondary autoimmune neutropenia. | Arthritis research & therapy 20050101 |
| Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20050101 |
| Genotypic prognostic markers. | Current topics in microbiology and immunology 20050101 |
| Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. | Annals of the New York Academy of Sciences 20050101 |
| Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL. | Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101 |
| Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. | Drugs & aging 20050101 |
| [Progress and perspectives in the treatment of systemic lupus erythematosus]. | Przeglad lekarski 20050101 |
| First two successful unrelated donor bone marrow transplantations for paroxysmal nocturnal hemoglobinuria in Poland. | Annals of transplantation 20050101 |
| [Mantle cell lymphoma mimicking chronic lymphocytic leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20050101 |
| Reduced-intensity allogeneic hematopoietic stem-cell transplantation as an immunotherapy for metastatic colorectal cancer. | Transplantation 20041227 |
| Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway. | Oncogene 20041216 |
| Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. | Blood 20041215 |
| Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. | Blood 20041201 |
| Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. | Leukemia 20041201 |
| Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. | Bone marrow transplantation 20041201 |
| Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. | Bone marrow transplantation 20041201 |
| Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer. | The journal of gene medicine 20041201 |
| Immunobiologic therapies for myelodysplastic syndrome. | Best practice & research. Clinical haematology 20041201 |
| Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies. | Bone marrow transplantation 20041201 |
| VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. | European journal of haematology 20041201 |
| The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro. | European journal of haematology 20041201 |
| The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia. | International journal of oncology 20041201 |
| Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage. | American journal of hematology 20041201 |
| Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
| Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma. | Haematologica 20041201 |
| A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity. | Haematologica 20041201 |
| Effect of fludarabine on leukocyte functions. | Chemotherapy 20041201 |
| Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. | Cell cycle (Georgetown, Tex.) 20041201 |
| Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation. | Leukemia & lymphoma 20041201 |
| Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia. | Leukemia & lymphoma 20041201 |
| Treatment options in Waldenstrom's macroglobulinemia. | Clinical lymphoma 20041201 |
| Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection. | International journal of hematology 20041201 |
| Megadose CD34+ hemopoietic stem cell transplantation for patients with high risk acute myeloid leukemia who have no HLA matched donor--a pilot study of a full haplotype mismatch transplantation. | The Korean journal of internal medicine 20041201 |
| Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia. | Saudi medical journal 20041201 |
| The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. | Blood 20041115 |
| Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. | Annals of hematology 20041101 |
| Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus. | Gene therapy 20041101 |
| A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies. | Cancer 20041101 |
| Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update. | Leukemia 20041101 |
| Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes. | Biochemical pharmacology 20041101 |
| Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion. | British journal of haematology 20041101 |
| Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041101 |
| Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis. | Leukemia & lymphoma 20041101 |
| Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect. | Leukemia & lymphoma 20041101 |
| Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study. | Nuclear medicine communications 20041101 |
| Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance. | Internal medicine (Tokyo, Japan) 20041101 |
| Unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous transplantation for multiple myeloma. | International journal of hematology 20041101 |
| Potential therapeutic applications of oblimersen in CLL. | Oncology (Williston Park, N.Y.) 20041101 |
| The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia. | Folia morphologica 20041101 |
| Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. | Blood 20041015 |
| Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. | Blood 20041015 |
| A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. | Transplantation 20041015 |
| A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041015 |
| How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041015 |
| Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin. | British journal of cancer 20041004 |
| Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041001 |
| Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma. | European journal of haematology 20041001 |
| Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells. | Leukemia 20041001 |
| Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. | Leukemia & lymphoma 20041001 |
| Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia. | Leukemia & lymphoma 20041001 |
| Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature. | Leukemia & lymphoma 20041001 |
| Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041001 |
| Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. | British journal of haematology 20041001 |
| Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001 |
| [Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study]. | Zhongguo shi yan xue ye xue za zhi 20041001 |
| Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia. | International journal of hematology 20041001 |
| Allogeneic bone marrow transplantation in beta-thalassaemia--single centre study. | JPMA. The Journal of the Pakistan Medical Association 20041001 |
| Clofarabine in adult acute leukemias: clinical success and pharmacokinetics. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. | Blood 20040915 |
| Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene. | Cancer research 20040915 |
| The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill. | Cancer research 20040915 |
| Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. | British journal of cancer 20040913 |
| Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. | Blood 20040901 |
| Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. | Blood 20040901 |
| Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20040901 |
| Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO). | Leukemia & lymphoma 20040901 |
| BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning. | Leukemia 20040901 |
| Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine. | The Annals of pharmacotherapy 20040901 |
| Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect. | Bone marrow transplantation 20040901 |
| The role of fludarabine in the treatment of follicular and mantle cell lymphoma. | Cancer 20040901 |
| [New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia]. | Orvosi hetilap 20040829 |
| Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). | British journal of cancer 20040816 |
| New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. | Blood 20040815 |
| Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040815 |
| Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia. | Neurology 20040810 |
| Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. | Blood 20040801 |
| In vitro assessment of nucleoside analogs in multiple myeloma. | Cancer chemotherapy and pharmacology 20040801 |
| Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. | Bone marrow transplantation 20040801 |
| Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity. | Bone marrow transplantation 20040801 |
| Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies. | European journal of haematology 20040801 |
| Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue. | Cancer biology & therapy 20040801 |
| Fatal peripheral neuropathy following FLA chemotherapy. | Clinical and laboratory haematology 20040801 |
| Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. | British journal of haematology 20040801 |
| Cytopenia and hematopoietic recovery after low intensity conditioning transplants. | Croatian medical journal 20040801 |
| Molecular genetics and its clinical relevance. | Hematology/oncology clinics of North America 20040801 |
| Antibody therapy for chronic lymphocytic leukemia: a promising new modality. | Hematology/oncology clinics of North America 20040801 |
| Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. | Arthritis and rheumatism 20040801 |
| The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. | Leukemia 20040701 |
| Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. | Bone marrow transplantation 20040701 |
| Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040701 |
| Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy. | Leukemia research 20040701 |
| Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin. | Leukemia research 20040701 |
| Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701 |
| The clinical and epidemiological burden of chronic lymphocytic leukaemia. | European journal of cancer care 20040701 |
| Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040701 |
| An update on the management of chronic lymphocytic leukaemia. | Expert opinion on pharmacotherapy 20040701 |
| Acute renal failure after nonmyeloablative hematopoietic cell transplantation. | Journal of the American Society of Nephrology : JASN 20040701 |
| 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells. | Molecular pharmacology 20040701 |
| Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. | Bone marrow transplantation 20040701 |
| Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. | Bone marrow transplantation 20040701 |
| Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up. | Experimental hematology 20040701 |
| Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. | Lancet (London, England) 20040701 |
| Advances in chemotherapy for chronic lymphocytic leukemia. | Seminars in hematology 20040701 |
| The role of stem cell transplantation in chronic lymphocytic leukemia. | Seminars in hematology 20040701 |
| Clinical trials for malignant lymphoma in Japan. | Japanese journal of clinical oncology 20040701 |
| Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus. | Leukemia & lymphoma 20040701 |
| Guillain-Barré syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20040701 |
| Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells. | Journal of experimental therapeutics & oncology 20040701 |
| Advances in the diagnosis and treatment of chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20040701 |
| Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615 |
| Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia. | Cancer 20040615 |
| Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. | Annals of hematology 20040601 |
| Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. | Bone marrow transplantation 20040601 |
| Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). | Leukemia 20040601 |
| Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection. | Blood 20040601 |
| Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040601 |
| Treatment of inflammatory and paraproteinemic neuropathies. | Current drug targets. Immune, endocrine and metabolic disorders 20040601 |
| Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen. | Haematologica 20040601 |
| Purine nucleoside antimetabolites in development for the treatment of cancer. | Current opinion in investigational drugs (London, England : 2000) 20040601 |
| Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group. | Leukemia & lymphoma 20040601 |
| Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study. | Leukemia & lymphoma 20040601 |
| High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients. | The Korean journal of internal medicine 20040601 |
| Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. | The Biochemical journal 20040515 |
| Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies. | Cancer 20040515 |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | Cancer 20040515 |
| Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions. | Blood 20040501 |
| Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. | Leukemia 20040501 |
| Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies. | Bone marrow transplantation 20040501 |
| Economic burden of acute myeloid leukemia: a literature review. | Cancer treatment reviews 20040501 |
| High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma. | Bone marrow transplantation 20040501 |
| Unusual case of subcutaneous panniculitis-like T-cell lymphoma. | The Australasian journal of dermatology 20040501 |
| Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. | Leukemia research 20040501 |
| Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium. | Leukemia research 20040501 |
| Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans. | Journal of the European Academy of Dermatology and Venereology : JEADV 20040501 |
| Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. | The American journal of surgical pathology 20040501 |
| Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040501 |
| Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease. | Cancer 20040501 |
| Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning. | Haematologica 20040501 |
| [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501 |
| Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20040501 |
| Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20040501 |
| The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients. | Blood 20040415 |
| Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease. | Annals of hematology 20040401 |
| Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. | Bone marrow transplantation 20040401 |
| Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor. | Bone marrow transplantation 20040401 |
| Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation. | Bone marrow transplantation 20040401 |
| Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. | Bone marrow transplantation 20040401 |
| Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen. | Bone marrow transplantation 20040401 |
| Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040401 |
| The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease. | American journal of hematology 20040401 |
| Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution. | British journal of haematology 20040401 |
| The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. | Cancer research 20040401 |
| Aspergillus fumigatus: a rare cause of vertebral osteomyelitis. | Haematologica 20040401 |
| Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040401 |
| The risk of cytomegalovirus infection in non-myeloablative peripheral stem cell transplantation compared with conventional bone marrow transplantation. | Journal of Korean medical science 20040401 |
| Nonmyeloablative allogeneic stem cell transplantation for patients with unresectable pancreatic cancer. | Pancreas 20040401 |
| [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20040401 |
| Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy. | Clinical nuclear medicine 20040401 |
| Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins. | Croatian medical journal 20040401 |
| A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia. | Leukemia research 20040401 |
| Treatment of chronic lymphocytic leukemia. | Seminars in oncology 20040401 |
| [Non-myeloablative stem cell transplantation from an HLA identical sibling donor in a case of treatment-related acute myelogenous leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040401 |
| Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia. | International journal of hematology 20040401 |
| [Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma]. | Revista brasileira de reumatologia 20040401 |
| [Waldenstrom macroglobulinemia]. | Praxis 20040331 |
| Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. | Blood 20040301 |
| Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis. | Bone marrow transplantation 20040301 |
| A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. | Bone marrow transplantation 20040301 |
| Reversible acute renal failure following single administration of fludarabine. | Bone marrow transplantation 20040301 |
| Nucleoside transporters in chronic lymphocytic leukaemia. | Leukemia 20040301 |
| Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. | The Journal of rheumatology 20040301 |
| Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. | British journal of haematology 20040301 |
| MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. | Arthritis and rheumatism 20040301 |
| [Reduced intensity stem cell transplantation for metastatic renal cell carcinoma]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040301 |
| In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. | Blood 20040215 |
| Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. | Blood 20040201 |
| Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. | Leukemia research 20040201 |
| Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy. | Pediatrics 20040201 |
| Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL). | American journal of hematology 20040201 |
| Antitumor activity of sugar-modified cytosine nucleosides. | Cancer science 20040201 |
| Nonmyeloablative stem cell transplantation for lymphoma. | Seminars in oncology 20040201 |
| Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion. | Seminars in oncology 20040201 |
| [Non-myeloablative allogeneic stem cell transplantation in patients with hematologic malignancies]. | Zhongguo shi yan xue ye xue za zhi 20040201 |
| [Decrease of chronic graft-versus-host disease by adding anti-human thymocyte globulin to the conditioning regimen]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040201 |
| Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. | The British journal of dermatology 20040201 |
| [Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040201 |
| Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report. | International journal of hematology 20040201 |
| Advancing therapy for chronic lymphocytic leukemia--the role of rituximab. | Seminars in oncology 20040201 |
| [Nonmyeloablative allogeneic stem cell transplantation for a 70-year-old woman with relapsed acute myelogenous leukemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040201 |
| Monoclonal antibodies in the treatment of chronic lymphoid leukemias. | Leukemia & lymphoma 20040201 |
| High dose chlorambucil in the treatment of lymphoid malignancies. | Leukemia & lymphoma 20040201 |
| An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines. | British journal of cancer 20040126 |
| Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. | Blood 20040115 |
| Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. | Blood 20040115 |
| Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040105 |
| Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. | Blood 20040101 |
| Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. | Blood 20040101 |
| Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions. | Leukemia 20040101 |
| Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. | Leukemia 20040101 |
| Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. | British journal of haematology 20040101 |
| Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20040101 |
| Treatment options for newly diagnosed patients with chronic lymphocytic leukemia. | Current hematology reports 20040101 |
| Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease. | The journal of gene medicine 20040101 |
| Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. | Experimental hematology 20040101 |
| Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine-induced hemolytic anemia: successful treatment by rituximab. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report. | Gynecologic oncology 20040101 |
| Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040101 |
| Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. | European journal of haematology 20040101 |
| Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection. | International journal of hematology 20040101 |
| Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study. | Leukemia & lymphoma 20040101 |
| Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Treatment options in chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Use of fludarabine in the treatment of acute myeloid leukemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Future prospects for fludarabine-containing regimens in the treatment of hematological cancers. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| [Autologous peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience]. | Reumatismo 20040101 |
| Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation. | Annals of hematology 20040101 |
| Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. | The Annals of pharmacotherapy 20040101 |
| Treatment of resistant/relapsing chronic lymphocytic leukemia with a combination regimen containing deoxycoformycin and rituximab. | Acta haematologica 20040101 |
| Fludarabine combination regimen severely affected peripheral blood stem cell mobilization. | Acta haematologica 20040101 |
| A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Fludarabine as the possible cause of acute myelofibrosis. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). | Journal of immunotherapy (Hagerstown, Md. : 1997) 20040101 |
| Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Purine analogs in leukemia. | Advances in pharmacology (San Diego, Calif.) 20040101 |
| Canadian multicenter pilot trial of haploidentical donor transplantation. | Blood cells, molecules & diseases 20040101 |
| Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. | Blood cells, molecules & diseases 20040101 |
| Chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20040101 |
| Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| [Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma]. | Casopis lekaru ceskych 20040101 |
| Effects of fludarabine treatment on murine lupus nephritis. | Lupus 20040101 |
| [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy]. | Voprosy onkologii 20040101 |
| T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. | Transplantation 20031227 |
| Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. | Transplantation 20031215 |
| Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia. | Cancer chemotherapy and pharmacology 20031201 |
| High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. | Annals of hematology 20031201 |
| In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. | Biochemical pharmacology 20031201 |
| Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies. | Clinical and laboratory haematology 20031201 |
| Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. | Transfusion 20031201 |
| Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201 |
| Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. | International journal of clinical oncology 20031201 |
| Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | Haematologica 20031201 |
| [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia]. | Ai zheng = Aizheng = Chinese journal of cancer 20031201 |
| B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen. | Transplantation proceedings 20031201 |
| [Hairy cell leukemia: report on one case with survival for 10 years]. | Zhongguo shi yan xue ye xue za zhi 20031201 |
| Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity. | Pediatric transplantation 20031201 |
| Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine. | Leukemia & lymphoma 20031201 |
| [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands]. | Nederlands tijdschrift voor geneeskunde 20031122 |
| Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. | Biochemical and biophysical research communications 20031121 |
| Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. | Blood 20031115 |
| Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. | Oncogene 20031113 |
| Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. | British journal of cancer 20031103 |
| Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. | Leukemia 20031101 |
| Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. | Journal of leukocyte biology 20031101 |
| Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. | Bone marrow transplantation 20031101 |
| The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. | Bone marrow transplantation 20031101 |
| Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. | Annals of the rheumatic diseases 20031101 |
| Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selection. | Experimental hematology 20031101 |
| Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. | Haematologica 20031101 |
| Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. | Journal of pediatric hematology/oncology 20031101 |
| Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma. | British journal of haematology 20031101 |
| Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation. | British journal of haematology 20031101 |
| Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031101 |
| Detection of two cell populations corresponding to distinct maturation stages in API-2/MLT-positive mucosa-associated lymphoid tissue lymphoma cells proliferating in pleural effusion. | International journal of hematology 20031101 |
| [Successful T-cell-replete peripheral blood stem cell transplantation from an HLA 2 loci mismatched mother to her son with refractory anemia in myelodysplastic syndrome]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20031101 |
| Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia. | Leukemia & lymphoma 20031101 |
| Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia. | Leukemia & lymphoma 20031101 |
| Clinical use of rituximab in haematological malignancies. | British journal of cancer 20031020 |
| Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. | Cancer chemotherapy and pharmacology 20031001 |
| Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia. | Leukemia research 20031001 |
| Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. | Toxicological sciences : an official journal of the Society of Toxicology 20031001 |
| Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. | Bone marrow transplantation 20031001 |
| Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia. | Bone marrow transplantation 20031001 |
| The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. | British journal of haematology 20031001 |
| Fludarabine-related myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001 |
| Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. | Leukemia 20031001 |
| Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. | Leukemia 20031001 |
| Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma. | Bone marrow transplantation 20031001 |
| Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. | Bone marrow transplantation 20031001 |
| Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome. | Journal of pediatric hematology/oncology 20031001 |
| Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors. | Experimental hematology 20031001 |
| Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen. | Experimental hematology 20031001 |
| Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases. | Experimental hematology 20031001 |
| Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome. | Experimental hematology 20031001 |
| Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031001 |
| [Modified FLAG regimen in the management of refractory acute myeloid leukemia]. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001 |
| Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001 |
| Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001 |
| Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001 |
| Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. | Leukemia & lymphoma 20031001 |
| Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia. | Leukemia & lymphoma 20031001 |
| Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia. | JPMA. The Journal of the Pakistan Medical Association 20031001 |
| [Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia]. | MMW Fortschritte der Medizin 20030925 |
| HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. | Blood 20030915 |
| Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia. | Blood 20030915 |
| Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. | Blood 20030901 |
| Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia. | Cancer chemotherapy and pharmacology 20030901 |
| Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity. | Annals of hematology 20030901 |
| Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. | Bone marrow transplantation 20030901 |
| A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. | Bone marrow transplantation 20030901 |
| A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| [Chimerism in allogeneic mini-transplantation]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Non-myeloablative or reduced intensity stem cell transplantation preparative regimens]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Mini-transplantation from HLA-mismatched donors]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Mini-transplantation from cord blood]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Reduced-intensity stem cell transplantation (RIST) for lymphoproliferative diseases]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Non-myeloablative stem cell transplantation for non-malignant hematologic disorders]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Gastrointestinal cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Nonmyeloablative allogeneic peripheral blood stem cell transplantation of renal cell carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro. | Leukemia & lymphoma 20030901 |
| [Unrelated HLA-mismatched cord blood transplantation using nonmyeloablative conditioning in an adult patient with very severe aplastic anemia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20030901 |
| Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815 |
| Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. | Blood 20030801 |
| Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. | Blood 20030801 |
| High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias. | Annals of hematology 20030801 |
| Bilateral optic disc swelling as the presenting sign of Waldenström's macroglobulinaemia. | Acta ophthalmologica Scandinavica 20030801 |
| Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. | Blood 20030801 |
| Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. | European journal of haematology 20030801 |
| A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement. | Clinical and laboratory haematology 20030801 |
| Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness. | Bone marrow transplantation 20030801 |
| Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20030801 |
| Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030801 |
| Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030801 |
| Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. | Haematologica 20030801 |
| Rituximab in B-cell chronic lymphocytic leukemia. | Seminars in oncology 20030801 |
| Alemtuzumab therapy in B-cell lymphoproliferative disorders. | Seminars in oncology 20030801 |
| Nonmyeloablative transplantation for lymphoma. | Current treatment options in oncology 20030801 |
| Mantle cell lymphoma. | Current treatment options in oncology 20030801 |
| Early reappearance of primary solid cancer in patients treated with purine analogs. | Journal of chemotherapy (Florence, Italy) 20030801 |
| [Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801 |
| [Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801 |
| Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. | Blood 20030715 |
| Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. | Blood 20030715 |
| Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715 |
| Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy. | Transplantation 20030715 |
| Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. | Transplantation 20030715 |
| [Current concepts in chronic lymphocytic leukemia. Better chances for young patients]. | MMW Fortschritte der Medizin 20030710 |
| Advances in the therapy of chronic lymphocytic leukemia. | Current opinion in hematology 20030701 |
| Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia. | European journal of haematology 20030701 |
| Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. | Bone marrow transplantation 20030701 |
| A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. | Bone marrow transplantation 20030701 |
| High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. | Bone marrow transplantation 20030701 |
| Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701 |
| Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia. | Bone marrow transplantation 20030701 |
| Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701 |
| Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701 |
| Reduced-intensity allogeneic stem cell transplantation. | Current hematology reports 20030701 |
| Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies. | Leukemia & lymphoma 20030701 |
| Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma. | Leukemia & lymphoma 20030701 |
| Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells. | Bulletin of experimental biology and medicine 20030701 |
| Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia. | The Journal of the Association of Physicians of India 20030701 |
| [Evidence-based therapy for chronic leukemia]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20030610 |
| Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma. | Annals of hematology 20030601 |
| Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. | Annals of hematology 20030601 |
| Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience. | Hematology (Amsterdam, Netherlands) 20030601 |
| Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study. | European journal of haematology 20030601 |
| Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. | Leukemia 20030601 |
| Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia. | Bone marrow transplantation 20030601 |
| Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning. | Bone marrow transplantation 20030601 |
| Mechanism of action of purine analogues in chronic lymphocytic leukaemia. | British journal of haematology 20030601 |
| Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. | British journal of haematology 20030601 |
| Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. | Bone marrow transplantation 20030601 |
| Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide. | Leukemia & lymphoma 20030601 |
| [Current status of reduced-intensity stem cell transplantation; survey in the Kinki area]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20030601 |
| Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience. | The Medical journal of Malaysia 20030601 |
| Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515 |
| Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? | Leukemia research 20030501 |
| Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation. | Annals of hematology 20030501 |
| Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H. | European journal of haematology 20030501 |
| Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine. | The Annals of pharmacotherapy 20030501 |
| Monoclonal antibody therapy of chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501 |
| Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. | Oncogene 20030501 |
| Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. | Bone marrow transplantation 20030501 |
| Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. | Bone marrow transplantation 20030501 |
| Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation. | Bone marrow transplantation 20030501 |
| Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. | Leukemia 20030501 |
| Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. | Leukemia 20030501 |
| Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. | Leukemia & lymphoma 20030501 |
| Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415 |
| A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice. | Transplantation 20030415 |
| Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans. | Transplantation 20030415 |
| Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. | Cancer 20030401 |
| Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401 |
| Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review. | American journal of hematology 20030401 |
| Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation. | British journal of haematology 20030401 |
| Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. | Haematologica 20030401 |
| Bilateral orbital masses in a patient with B-cell chronic lymph. | Haematologica 20030401 |
| Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies. | British journal of haematology 20030401 |
| FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. | Annals of hematology 20030401 |
| Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine. | Annals of hematology 20030401 |
| Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. | Cell death and differentiation 20030401 |
| Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. | Seminars in oncology 20030401 |
| Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003). | Seminars in oncology 20030401 |
| Fludarabine in Waldenstrom's macroglobulinemia. | Seminars in oncology 20030401 |
| Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia. | Seminars in oncology 20030401 |
| Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030401 |
| Unrelated umbilical cord blood transplant for beta-thalassemia major. | Journal of tropical pediatrics 20030401 |
| Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment. | Leukemia & lymphoma 20030401 |
| Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy. | Leukemia & lymphoma 20030401 |
| Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. | Blood 20030315 |
| Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes. | Statistics in medicine 20030315 |
| Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. | Cancer 20030315 |
| Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines. | Bioorganic & medicinal chemistry letters 20030310 |
| Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. | British journal of cancer 20030310 |
| Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty. | Blood 20030301 |
| Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. | American journal of hematology 20030301 |
| Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. | American journal of hematology 20030301 |
| Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment. | Archives of dermatology 20030301 |
| Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved. | Bone marrow transplantation 20030301 |
| Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. | Bone marrow transplantation 20030301 |
| Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita. | Bone marrow transplantation 20030301 |
| Unrelated bone marrow transplantation for beta-thalassemia major: report of the first 2 successful cases in Asia. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20030301 |
| Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia. | Haematologica 20030301 |
| Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC). | Haematologica 20030301 |
| Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301 |
| Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301 |
| Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. | Bone marrow transplantation 20030301 |
| Nongastric mucosa-associated lymphoid tissue lymphomas. | Clinical lymphoma 20030301 |
| Purine nucleoside analogues in the treatment of myleoid leukemias. | Leukemia & lymphoma 20030301 |
| Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia. | Leukemia & lymphoma 20030301 |
| Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs. | Leukemia & lymphoma 20030301 |
| Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature. | Leukemia & lymphoma 20030301 |
| Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. | Blood 20030215 |
| [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation]. | Zhonghua yi xue za zhi 20030210 |
| Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. | American journal of hematology 20030201 |
| Advances in the treatment of hairy-cell leukaemia. | The Lancet. Oncology 20030201 |
| Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. | British journal of haematology 20030201 |
| The relevance of nonmyeloablative transplants in developing countries: lessons from the UK experience. | Transplantation proceedings 20030201 |
| A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. | Leukemia 20030201 |
| CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation. | Haematologica 20030201 |
| Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. | Haematologica 20030201 |
| Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. | Bone marrow transplantation 20030201 |
| Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant. | Bone marrow transplantation 20030201 |
| Rituximab plus chemotherapy in follicular and mantle cell lymphomas. | Seminars in oncology 20030201 |
| Rituximab in chronic lymphocytic leukemia. | Seminars in oncology 20030201 |
| [Two HLA-loci mismatched sibling cord blood transplantation in a severe beta-thalassemia patient]. | Zhongguo shi yan xue ye xue za zhi 20030201 |
| Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine. | Leukemia & lymphoma 20030201 |
| Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility. | Leukemia & lymphoma 20030201 |
| DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia. | Expert opinion on biological therapy 20030201 |
| Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. | Blood 20030115 |
| Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. | Blood 20030115 |
| The effects of cladribine and fludarabine on DNA methylation in K562 cells. | Biochemical pharmacology 20030115 |
| Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. | Biochemical pharmacology 20030115 |
| Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). | Blood 20030101 |
| Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. | Cancer 20030101 |
| Newer drugs for the treatment of lupus nephritis. | Drugs 20030101 |
| Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030101 |
| Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission. | British journal of haematology 20030101 |
| Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications. | Oncology (Williston Park, N.Y.) 20030101 |
| Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia. | Bone marrow transplantation 20030101 |
| Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. | Bone marrow transplantation 20030101 |
| Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. | Bone marrow transplantation 20030101 |
| Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. | Acta haematologica 20030101 |
| Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101 |
| Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma. | Medical oncology (Northwood, London, England) 20030101 |
| In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential. | Leukemia & lymphoma 20030101 |
| The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro. | Archivum immunologiae et therapiae experimentalis 20030101 |
| Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol. | Cell cycle (Georgetown, Tex.) 20030101 |
| New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. | Drugs 20030101 |
| [Long-term results of treatment of chronic B-cell lymphoid leukocytes in persons who participated in the elimination of the effects of the nuclear accident at the Chernobyl nuclear station]. | Likars'ka sprava 20030101 |
| B cells as a therapeutic target in autoimmune disease. | Arthritis research & therapy 20030101 |
| Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma. | Urologic oncology 20030101 |
| Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab. | The hematology journal : the official journal of the European Haematology Association 20030101 |
| Alemtuzumab. | Drugs 20030101 |
| The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases. | Immunologic research 20030101 |
| Oral fludarabine. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by Dieter Huhn. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by David Oscier. | Drugs 20030101 |
| Oral fludarabine: a viewpoint by Bruce D. Cheson. | Drugs 20030101 |
| Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantation. | Archives of medical research 20030101 |
| [Cytogenetic changes in the Namalwa cell line of human malignant lymphoma induced by inhibitors of DNA replication and synthesis]. | TSitologiia i genetika 20030101 |
| Biology and treatment of chronic lymphocytic leukemia. | Hematology. American Society of Hematology. Education Program 20030101 |
| Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia. | Neoplasma 20030101 |
| Traditional treatment approaches in B-cell non-Hodgkin's lymphoma. | Leukemia & lymphoma 20030101 |
| Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis. | Arthritis research & therapy 20030101 |
| Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma. | Leukemia & lymphoma 20030101 |
| Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine). | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20030101 |
| Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. | Transplantation 20021227 |
| Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. | Blood 20021215 |
| Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. | Blood 20021215 |
| Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. | Blood 20021215 |
| Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. | Blood 20021201 |
| Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. | British journal of haematology 20021201 |
| A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. | British journal of haematology 20021201 |
| Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia. | British journal of haematology 20021201 |
| Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. | British journal of haematology 20021201 |
| Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. | British journal of haematology 20021201 |
| Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. | Transfusion 20021201 |
| Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning? | Bone marrow transplantation 20021201 |
| Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma. | Bone marrow transplantation 20021201 |
| Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. | Bone marrow transplantation 20021201 |
| Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. | Clinical lymphoma 20021201 |
| Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. | Haematologica 20021201 |
| Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. | Journal of experimental & clinical cancer research : CR 20021201 |
| Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia. | Leukemia research 20021101 |
| The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. | Blood 20021101 |
| Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia. | Blood 20021101 |
| Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. | Blood 20021101 |
| Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen. | British journal of haematology 20021101 |
| Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha. | American journal of hematology 20021101 |
| Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine. | Haematologica 20021101 |
| Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience. | Bone marrow transplantation 20021101 |
| Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning. | Experimental hematology 20021101 |
| Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. | Vox sanguinis 20021101 |
| [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia]. | Revue neurologique 20021101 |
| [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20021101 |
| [Persistent T-cell mixed chimerism in a case of malignant lymphoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20021101 |
| Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation. | Transplantation 20021027 |
| [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]. | Deutsche medizinische Wochenschrift (1946) 20021025 |
| Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. | Virology 20021025 |
| The triterpenoid CDDO induces apoptosis in refractory CLL B cells. | Blood 20021015 |
| CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence? | American journal of hematology 20021001 |
| In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. | Leukemia 20021001 |
| Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. | Leukemia 20021001 |
| Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications. | Clinical and laboratory haematology 20021001 |
| Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. | British journal of haematology 20021001 |
| Chronic lymphocytic leukaemia: only treat when symptomatic. | Prescrire international 20021001 |
| The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas. | Anti-cancer drugs 20021001 |
| Monoclonal antibody therapies in leukemias. | Seminars in hematology 20021001 |
| Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. | Blood 20020915 |
| Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. | Blood 20020915 |
| Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Waldenström's macroglobulinaemia. | Blood reviews 20020901 |
| Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. | Blood 20020901 |
| Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. | Molecular pharmacology 20020901 |
| Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study. | Leukemia 20020901 |
| Fludarabine treatment of cryoglobulinemic glomerulonephritis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901 |
| B-chronic lymphocytic leukemia: practical aspects. | Hematological oncology 20020901 |
| In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation. | International journal of cancer 20020901 |
| Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. | Haematologica 20020901 |
| Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis. | American journal of hematology 20020901 |
| Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. | Chest 20020901 |
| Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors. | Bone marrow transplantation 20020901 |
| Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. | Bone marrow transplantation 20020901 |
| Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. | Bone marrow transplantation 20020901 |
| Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli). | Bone marrow transplantation 20020901 |
| Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma. | Annals of hematology 20020901 |
| Prolymphocytic leukaemia and Hodgkin's lymphoma. | European journal of haematology 20020901 |
| Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome. | The Israel Medical Association journal : IMAJ 20020901 |
| [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine]. | Polskie Archiwum Medycyny Wewnetrznej 20020901 |
| Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. | Leukemia & lymphoma 20020901 |
| Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation. | Leukemia & lymphoma 20020901 |
| Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia. | Leukemia & lymphoma 20020901 |
| Vaccine therapies for non-Hodgkin's lymphoma. | Current treatment options in oncology 20020801 |
| Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. | Blood 20020801 |
| Corticosteroid responsive fludarabine pulmonary toxicity. | American journal of clinical oncology 20020801 |
| Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphoma. | American journal of clinical oncology 20020801 |
| Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives. | Seminars in oncology 20020801 |
| FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies. | Leukemia research 20020801 |
| Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. | Journal of hematotherapy & stem cell research 20020801 |
| Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. | Bone marrow transplantation 20020801 |
| Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes. | European journal of haematology 20020801 |
| Waldenström's macroglobulinemia: a review of therapy. | Leukemia & lymphoma 20020801 |
| Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome. | Leukemia & lymphoma 20020801 |
| Haploidentical stem cell transplantation for acute leukemia. | International journal of hematology 20020801 |
| Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. | International journal of hematology 20020801 |
| Mini-transplantation strategy for solid tumors. | International journal of hematology 20020801 |
| [Clinical pharmacology of nucleoside analogues]. | Bulletin du cancer 20020801 |
| Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. | Expert review of anticancer therapy 20020801 |
| Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. | Transplantation 20020715 |
| Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. | Oncogene 20020704 |
| Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. | Blood 20020701 |
| Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine. | Haematologica 20020701 |
| The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use. | Haematologica 20020701 |
| Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation. | Haematologica 20020701 |
| Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine. | Haematologica 20020701 |
| Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning. | British journal of haematology 20020701 |
| Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study. | Cancer chemotherapy and pharmacology 20020701 |
| Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas. | American journal of hematology 20020701 |
| Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature. | American journal of hematology 20020701 |
| Cast nephropathy in a case of Waldenström's macroglobulinemia. | Nephron 20020701 |
| Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. | Bone marrow transplantation 20020701 |
| [Chronic myelogenous leukemia treated with non-myeloablative stem cell transplantation after discontinuing myeloablative stem cell transplantation due to mental aberrations]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20020701 |
| Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. | European journal of haematology 20020701 |
| [Experience with fludarabine treatment and review of the literature]. | Orvosi hetilap 20020616 |
| Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. | British journal of cancer 20020605 |
| Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. | Blood 20020601 |
| Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. | Haematologica 20020601 |
| Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. | Leukemia 20020601 |
| Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models. | Gene therapy 20020601 |
| Chronic lymphocytic leukemia. | Current treatment options in oncology 20020601 |
| Challenges in treating hematologic malignancies. | Seminars in oncology 20020601 |
| Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. | Bone marrow transplantation 20020601 |
| Troxacitabine-based therapy of refractory leukemia. | Expert review of anticancer therapy 20020601 |
| Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia. | Clinical lymphoma 20020601 |
| Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. | Clinical lymphoma 20020601 |
| Gateways to Clinical Trials. June 2002. | Methods and findings in experimental and clinical pharmacology 20020601 |
| Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. | Blood 20020515 |
| Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning. | British journal of cancer 20020506 |
| CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia. | Leukemia research 20020501 |
| HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. | Blood 20020501 |
| Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. | The American journal of surgical pathology 20020501 |
| Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. | American journal of hematology 20020501 |
| Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease. | American journal of hematology 20020501 |
| Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. | Cancer 20020501 |
| Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. | Annals of hematology 20020501 |
| Fludarabine-induced eosinophilia: case report. | Annals of hematology 20020501 |
| Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay. | Japanese journal of cancer research : Gann 20020501 |
| A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020501 |
| Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy. | The Netherlands journal of medicine 20020501 |
| Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020415 |
| Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population. | Cancer 20020401 |
| Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. | Leukemia 20020401 |
| Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission. | Leukemia 20020401 |
| Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine. | Bone marrow transplantation 20020401 |
| Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. | Journal of hematotherapy & stem cell research 20020401 |
| Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases. | Pathology 20020401 |
| The role of mitoxantrone in non-Hodgkin's lymphoma. | Oncology (Williston Park, N.Y.) 20020401 |
| Immunochemotherapy in indolent non-Hodgkin's lymphoma. | Seminars in oncology 20020401 |
| [Fludarabine as primary therapeutic drug in chronic lymphatic leukemia]. | Der Internist 20020401 |
| De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG). | European journal of haematology 20020401 |
| Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020401 |
| [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401 |
| Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders. | Leukemia & lymphoma 20020401 |
| Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. | Blood 20020315 |
| Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. | Blood 20020315 |
| Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. | Journal of leukocyte biology 20020301 |
| Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. | Haematologica 20020301 |
| High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma. | British journal of haematology 20020301 |
| Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis. | Mayo Clinic proceedings 20020301 |
| Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. | American journal of hematology 20020301 |
| Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. | Bone marrow transplantation 20020301 |
| Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma. | Clinical lymphoma 20020301 |
| Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020301 |
| The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials. | Leukemia & lymphoma 20020301 |
| Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes. | Toxicology 20020227 |
| The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. | Blood 20020201 |
| Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. | Blood 20020201 |
| Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. | Blood 20020201 |
| Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. | Haematologica 20020201 |
| Hematopoietic cell transplantation beyond first remission. | Leukemia 20020201 |
| Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome. | British journal of haematology 20020201 |
| Rituximab in combination with CHOP or fludarabine in low-grade lymphoma. | Seminars in oncology 20020201 |
| Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone. | Seminars in oncology 20020201 |
| Emerging information on the use of rituximab in chronic lymphocytic leukemia. | Seminars in oncology 20020201 |
| Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma. | Cancer 20020201 |
| Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). | Bone marrow transplantation 20020201 |
| Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. | Leukemia & lymphoma 20020201 |
| Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. | Leukemia & lymphoma 20020201 |
| Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication? | European journal of haematology 20020201 |
| Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma. | European journal of haematology 20020201 |
| Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. | Blood 20020115 |
| Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. | Blood 20020101 |
| Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. | Experimental hematology 20020101 |
| Nonmyeloablative allogeneic peripheral blood stem cell transplantation for multifocal extramedullary plasmacytomas progressing after autologous transplantation. | Bone marrow transplantation 20020101 |
| Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. | International journal of hematology 20020101 |
| Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Cellular and clinical pharmacology of fludarabine. | Clinical pharmacokinetics 20020101 |
| Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer. | Cancer treatment and research 20020101 |
| Outpatient allografting in hematologic malignancies and nonmalignant disorders--applying lessons learned in the canine model to humans. | Cancer treatment and research 20020101 |
| Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation. | Cancer treatment and research 20020101 |
| Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group. | Leukemia & lymphoma 20020101 |
| Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen. | European journal of haematology 20020101 |
| Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate. | Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna 20020101 |
| A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20020101 |
| Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial. | BMC cancer 20020101 |
| Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. | Health technology assessment (Winchester, England) 20020101 |
| [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: 'minitransplant']. | Gaceta medica de Mexico 20020101 |
| Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101 |
| Current and developing chemotherapy for CLL. | Medical oncology (Northwood, London, England) 20020101 |
| Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20020101 |
| Future prospects for alemtuzumab (MabCampath). | Medical oncology (Northwood, London, England) 20020101 |
| Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation. | Cytotherapy 20020101 |
| Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101 |
| Waldenström's macroglobulinemia. | Clinical journal of oncology nursing 20020101 |
| Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101 |
| The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study. | Cancer investigation 20020101 |
| The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. | Cancer treatment and research 20020101 |
| Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia. | Medical oncology (Northwood, London, England) 20020101 |
| High molecular weight DNA fragmentation assay: a sensitive method for monitoring in vivo response to antileukemic chemotherapy. | Anticancer research 20020101 |
| [Autologous stem cell transplantation in a patient with diffuse systemic sclerosis]. | Reumatismo 20020101 |
| Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. | Annals of hematology 20020101 |
| Facial paresis after fludarabine treatment for advanced chronic lymphocytic leukaemia. | Haematologia 20020101 |
| Costs of toxicity during chemotherapy with CHOP, COP/CVP, and fludarabine. | The European journal of health economics : HEPAC : health economics in prevention and care 20020101 |
| Analysis of recurrent failure times data: should the baseline hazard be stratified? | Statistics in medicine 20011230 |
| Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts. | Blood 20011215 |
| Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. | Blood 20011215 |
| Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. | Blood 20011215 |
| Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. | Cancer research 20011215 |
| Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. | Blood 20011201 |
| Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. | British journal of haematology 20011201 |
| Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. | British journal of haematology 20011201 |
| Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. | Leukemia 20011201 |
| Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab. | American journal of hematology 20011201 |
| [Allogeneic peripheral blood stem cell transplantation for 3 patients with beta-thalassemia major and 1 patient with congenital idiopathic haemolytic anemia]. | Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20011201 |
| Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. | British journal of haematology 20011201 |
| Stem cell transplantation eliminates alloantibody in a highly sensitized patient. | Transplantation 20011127 |
| Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115 |
| Clinical significance of CD38 expression in chronic lymphocytic leukemia. | Blood 20011101 |
| Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. | Blood 20011101 |
| Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. | Blood 20011101 |
| Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. | Haematologica 20011101 |
| DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011101 |
| Progress in CLL, chemotherapy, antibodies and transplantation. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20011101 |
| [Chronic lymphocytic leukemias]. | Nihon rinsho. Japanese journal of clinical medicine 20011101 |
| Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. | Blood 20011015 |
| Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. | Blood 20011015 |
| High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens. | Cancer 20011015 |
| Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. | Cancer 20011015 |
| Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. | Leukemia 20011001 |
| Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. | Haematologica 20011001 |
| Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation. | The Journal of rheumatology. Supplement 20011001 |
| Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient. | Journal of thoracic imaging 20011001 |
| Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine. | Thrombosis and haemostasis 20011001 |
| A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. | Bone marrow transplantation 20011001 |
| Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. | Bone marrow transplantation 20011001 |
| Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. | British journal of haematology 20011001 |
| Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. | Bone marrow transplantation 20011001 |
| Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure. | Bone marrow transplantation 20011001 |
| Identification and characterization of human deoxyguanosine kinase cDNA fragments. | Cancer letters 20010920 |
| Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis. | Leukemia 20010901 |
| Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation. | Haematologica 20010901 |
| Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. | British journal of haematology 20010901 |
| Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis. | Journal of neuropathology and experimental neurology 20010901 |
| Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone. | British journal of haematology 20010901 |
| Therapeutic options for acute myelogenous leukemia. | Cancer 20010901 |
| [Recent progress in the treatment of malignant lymphoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010901 |
| Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. | Bone marrow transplantation 20010901 |
| Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. | Annals of hematology 20010901 |
| Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. | Annals of hematology 20010901 |
| Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010815 |
| Developing a pediatric outpatient transplantation program. The Children's Memorial Hospital experience. | Frontiers in bioscience : a journal and virtual library 20010801 |
| Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. | British journal of haematology 20010801 |
| Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. | Bone marrow transplantation 20010801 |
| Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein. | Cancer chemotherapy and pharmacology 20010801 |
| Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy. | Bone marrow transplantation 20010801 |
| Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia. | Onkologie 20010801 |
| [Drug-induced hemolytic anemia]. | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010801 |
| Infectious complications of purine analog therapy. | Current opinion in infectious diseases 20010801 |
| Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? | Transplantation 20010727 |
| Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715 |
| Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells. | Biochemical pharmacology 20010701 |
| Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). | Blood 20010701 |
| Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. | Journal of clinical epidemiology 20010701 |
| Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. | British journal of haematology 20010701 |
| Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. | Bone marrow transplantation 20010701 |
| Acute left ventricular failure following melphalan and fludarabine conditioning. | Bone marrow transplantation 20010701 |
| Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. | Bone marrow transplantation 20010701 |
| Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation. | Bone marrow transplantation 20010701 |
| Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. | International journal of hematology 20010701 |
| Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia. | Leukemia & lymphoma 20010701 |
| Recent advances in the management of adult myositis. | Expert opinion on investigational drugs 20010701 |
| [Chronic lymphocytic leukemia. 2. Therapy]. | Deutsche medizinische Wochenschrift (1946) 20010608 |
| [Chronic lymphatic leukemia. 3. The concrete case]. | Deutsche medizinische Wochenschrift (1946) 20010608 |
| UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism. | Experimental hematology 20010601 |
| Nucleoside analogues: mechanisms of drug resistance and reversal strategies. | Leukemia 20010601 |
| Paraneoplastic pemphigus: an association with fludarabine? | The British journal of dermatology 20010601 |
| Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. | Annals of the New York Academy of Sciences 20010601 |
| Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias. | Annals of hematology 20010601 |
| Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. | Journal of experimental & clinical cancer research : CR 20010601 |
| Non-myeloablative hematopoietic stem cell transplantation. | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010601 |
| Combination chemotherapy and rituximab. | Anti-cancer drugs 20010601 |
| Nucleoside analogues in the treatment of haematological malignancies. | Expert opinion on pharmacotherapy 20010601 |
| Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues. | Expert opinion on pharmacotherapy 20010601 |
| Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens. | Leukemia & lymphoma 20010601 |
| [Pneumonia in patients with chronic lymphocytic leukemia. Study of 30 episodes]. | Medicina clinica 20010526 |
| Novel treatment strategies in chronic lymphocytic leukemia. | Current oncology reports 20010501 |
| Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia. | Journal of clinical pathology 20010501 |
| Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis. | Pharmacotherapy 20010501 |
| A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma. | The British journal of dermatology 20010501 |
| Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia? | Leukemia & lymphoma 20010501 |
| Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| [Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain]. | Medicina clinica 20010428 |
| [Molecular biology examination in chronic lymphocytic leukemia]. | Orvosi hetilap 20010422 |
| Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Fludarabine for chronic lymphocytic leukemia. | The New England journal of medicine 20010412 |
| Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. | Blood 20010401 |
| Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. | American journal of hematology 20010401 |
| Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis. | Archives of disease in childhood 20010401 |
| Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation. | Leukemia 20010401 |
| Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia. | Leukemia & lymphoma 20010401 |
| [Mantle cell lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20010401 |
| Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine. | Onkologie 20010401 |
| Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. | Bone marrow transplantation 20010401 |
| Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. | The New England journal of medicine 20010322 |
| Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301 |
| Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML. | British journal of cancer 20010301 |
| Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. | Haematologica 20010301 |
| Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. | British journal of haematology 20010301 |
| New drug combinations for the treatment of murine AIDS and macrophage protection. | European journal of clinical investigation 20010301 |
| Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. | Experimental hematology 20010301 |
| Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010301 |
| Biological and molecular characterization of PNH-like lymphocytes emerging after Campath-1H therapy. | British journal of haematology 20010301 |
| Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia. | Bone marrow transplantation 20010301 |
| Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome. | Annals of hematology 20010301 |
| Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma. | Leukemia & lymphoma 20010301 |
| Reversal of fludarabine induced testicular damage in a patient with chronic lymphocytic leukaemia (CLL), by suppression of pituitary-testicular axis using gonadotrophin releasing hormone (GnRH). | Leukemia & lymphoma 20010301 |
| Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010215 |
| Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. | Blood 20010201 |
| Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment. | British journal of haematology 20010201 |
| Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. | British journal of haematology 20010201 |
| A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment. | British journal of haematology 20010201 |
| Bilateral breast relapse in acute myelogenous leukemia. | Journal of pediatric hematology/oncology 20010201 |
| Reactivation of hepatitis B virus infection during cytotoxic chemotherapy. | The American journal of gastroenterology 20010201 |
| Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010201 |
| Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenström's macroglobulinaemia. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010201 |
| Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment. | Leukemia & lymphoma 20010201 |
| Cladribine in the treatment of chronic lymphocytic leukemia. | Leukemia & lymphoma 20010201 |
| Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma. | Leukemia & lymphoma 20010201 |
| Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma. | Leukemia research 20010101 |
| Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report. | Haematologica 20010101 |
| Red swollen nail folds and nail deformity as presenting findings in chronic lymphocytic leukaemia. | British journal of haematology 20010101 |
| A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. | British journal of haematology 20010101 |
| Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells. | Leukemia 20010101 |
| Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease. | Bone marrow transplantation 20010101 |
| Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. | Bone marrow transplantation 20010101 |
| Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia. | Bone marrow transplantation 20010101 |
| A fludarabine-based conditioning regimen for severe aplastic anemia. | Bone marrow transplantation 20010101 |
| Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). | Bone marrow transplantation 20010101 |
| Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101 |
| Achieving optimal outcomes in chronic lymphocytic leukaemia. | Drugs 20010101 |
| Second allogeneic peripheral blood stem cell transplantation with fludarabine-based low-intensity conditioning regimen for relapsed myelodysplastic syndrome after allogeneic bone marrow transplantation. | International journal of hematology 20010101 |
| Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. | Acta haematologica 20010101 |
| Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. | Journal of cancer research and clinical oncology 20010101 |
| Treatment of 'poor risk' acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study. | Leukemia & lymphoma 20010101 |
| First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia. | Leukemia & lymphoma 20010101 |
| Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen. | Leukemia & lymphoma 20010101 |
| Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia. | Leukemia & lymphoma 20010101 |
| A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia. | Acta oncologica (Stockholm, Sweden) 20010101 |
| Application of high-performance, thin-layer chromatography to quality control of antimetabolite analogue infusion bags. | Journal of AOAC International 20010101 |
| Alemtuzumab (Millennium/ILEX). | Current opinion in investigational drugs (London, England : 2000) 20010101 |
| Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma. | Leukemia & lymphoma 20010101 |
| Carboxyamido-triazole (CAI)--a novel 'static' signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20010101 |
| Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma. | Leukemia & lymphoma 20010101 |
| Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies. | The oncologist 20010101 |
| Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern. | European journal of dermatology : EJD 20010101 |
| Chronic lymphocytic leukaemia. | Clinical medicine (London, England) 20010101 |
| Chronic lymphocytic leukemia: case-based session. | Hematology. American Society of Hematology. Education Program 20010101 |
| Non-myeloablative transplants for malignant disease. | Hematology. American Society of Hematology. Education Program 20010101 |
| Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells. | Anticancer research 20010101 |
| [Lupus nephritis: treatments for today and tomorrow]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101 |
| The bioavailability of oral fludarabine phosphate is unaffected by food. | The hematology journal : the official journal of the European Haematology Association 20010101 |
| [Nucleoside analogues--new drugs for the treatment of lymphatic cancers]. | Duodecim; laaketieteellinen aikakauskirja 20010101 |
| Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. | Cytotherapy 20010101 |
| In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. | Cytotherapy 20010101 |
| Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion. | Cytotherapy 20010101 |
| [Non-myeloablative therapy and allogeneic hematopoietic stem cell transplantation in hematologic malignancies]. | Polskie Archiwum Medycyny Wewnetrznej 20010101 |